Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3036086	s-jo1ab	— (—)	7743	9187	100.00%	Distribution not available
3036086	jo-1	— (—)	988	1129	100.00%	Distribution not available
3036086	s-jo1ab	u/ml (u/ml)	102	144	0.00%
3036086	jo-1	u/ml (u/ml)	22	36	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Systemic sclerosis, icd10

265

178

21.00

314.41

1.5

1.2

0.41

—

u/ml

—

Seropositive rheumatoid arthritis

656

1291

5.30

314.04

1.2

1.1

12.73

0.47

u/ml

—

Reimbursement for rheumatic diseases

2096

4372

5.06

307.65

1.4

1.2

15.54

9.70

u/ml

0.47

Mixed connective tissue disease

597

447

17.25

307.65

1.7

1.1

17.41

0.60

u/ml

—

Other systemic involvement of connective tissue

1637

1737

10.68

307.65

1.5

1.1

13.76

0.58

u/ml

2.49

Second line medication for Crohn's disease

1811

4440

4.28

307.65

1.3

1.2

23.95

6.49

u/ml

1.83

Other arthritis (FG)

856

1621

5.53

307.65

1.3

1.1

21.13

0.43

u/ml

—

Interstitial lung disease endpoints

685

797

9.59

307.65

1.2

45.58

0.62

u/ml

—

Other soft tissue disorders, not elsewhere classified

2002

4560

2.77

307.65

1.3

1.2

6.42

16.51

u/ml

0.86

Sicca syndrome [Sjögren]

685

482

17.55

307.65

1.5

1.1

8.98

0.47

u/ml

—

Systemic connective tissue disorders

2215

2244

11.24

307.65

1.5

1.1

14.70

0.58

u/ml

3.28

Pain in joint

1677

2725

4.22

307.65

1.3

1.2

19.70

15.77

u/ml

0.13

Finngen Rheumatological endpoints

2703

3602

4.42

307.65

1.3

1.1

15.05

18.08

u/ml

0.12

Other interstitial pulmonary diseases

685

797

9.59

307.65

1.2

45.57

0.62

u/ml

—

Other specified/unspecified arthritis

772

1527

5.31

307.65

1.3

1.2

15.07

24.12

u/ml

0.27

First line medication for Crohn's disease

2758

4478

3.45

307.65

1.3

1.2

18.47

9.43

u/ml

0.66

Other peripheral vascular diseases

447

522

9.78

307.65

1.4

1.2

15.18

7.04

u/ml

—

Polyarthropathies

1917

2930

4.52

307.65

1.3

1.2

15.50

16.48

u/ml

0.04

Interstitial lung disease

685

797

9.59

307.65

1.2

45.57

0.62

u/ml

—

Oral corticosteroids

2878

4802

3.74

307.65

1.3

1.2

17.73

9.56

u/ml

0.62

Autoimmune diseases excluding thyroid diseases, strict definition

2767

3872

4.11

307.65

1.3

1.1

16.12

10.32

u/ml

0.45

Other respiratory diseases principally affecting the interstitium

713

946

8.25

307.65

1.2

45.57

0.56

u/ml

—

Other systemic involvement of connective tissue (FG)

1625

1291

14.24

307.65

1.5

1.1

13.76

0.44

u/ml

—

Systemic sclerosis

267

128

29.50

307.65

1.5

1.1

0.41

—

u/ml

—

Rheumatoid arthritis

941

1709

5.24

307.65

1.2

15.45

19.30

u/ml

0.13

Other specific joint derangements/joint disorders

1926

3289

4.05

307.65

1.3

1.2

15.50

15.28

u/ml

0.01

Autoimmune diseases related-to ILD

2372

5509

3.92

307.65

1.4

1.2

12.16

10.67

u/ml

0.09

ILD medications: immunosuppressive drugs

2124

3744

5.73

307.65

1.3

1.2

23.65

11.92

u/ml

0.72

Autoimmune diseases

2489

4004

3.25

307.65

1.3

1.1

17.64

9.98

u/ml

0.56

Inflammatory bowel disease treatment related agents

3035

4942

3.59

307.65

1.3

1.2

17.38

9.38

u/ml

0.61

ILD medications: prednisolone, methylprednisolone, prednisone

2953

4234

4.07

307.65

1.3

1.2

17.65

10.69

u/ml

0.44

ILD medications

3148

4301

4.15

307.65

1.3

1.2

17.14

10.69

u/ml

0.40

Autoimmune diseases excluding thyroid diseases

2839

3973

4.09

307.65

1.3

1.1

15.41

9.98

u/ml

0.42

Used for control exclusion in common control thyroid runs

2250

3701

3.15

307.65

1.3

1.1

21.02

11.50

u/ml

0.60

L04AX Other immunosuppressants

1781

4326

4.32

307.65

1.3

1.2

23.95

6.62

u/ml

1.79

ILD, hospital admissions

685

782

9.80

307.65

1.2

45.58

0.62

u/ml

—

ILD, hospital admissions 1, main diag only

620

715

9.73

307.65

1.2

45.57

0.62

u/ml

—

Arthropathies

1841

3359

2.84

301.68

1.2

24.82

15.48

u/ml

0.39

Rheumatoid arthritis, including avohilmo

1039

3013

3.60

298.85

1.2

14.62

11.18

u/ml

0.15

Other joint disorders

1733

3351

2.81

282.15

1.2

15.47

15.48

u/ml

0.00

Other and unspecified dermatitis

1209

4028

3.10

275.73

1.3

1.2

12.73

15.83

u/ml

0.16

Dermatitis

1349

4836

2.87

268.81

1.3

1.2

12.73

15.99

u/ml

0.18

Dermatitis and eczema

2202

6295

2.34

263.97

1.3

1.2

12.65

14.82

u/ml

0.14

ILD, hospital admission 2, with pulmonary infections

375

513

8.01

262.60

1.2

1.1

33.26

10.98

u/ml

—

Diseases of the musculoskeletal system and connective tissue

986

1326

3.80

248.88

1.2

1.1

5.67

17.74

u/ml

—

Medical observation and evaluation for suspected diseases and conditions

1405

2485

2.95

246.42

1.3

1.2

19.55

14.78

u/ml

0.20

Polyarthrosis

508

1011

5.05

226.65

1.2

0.46

22.63

u/ml

—

CR(E)ST syndrome

177

108

24.04

221.35

1.5

1.2

0.41

—

u/ml

—

Abnormal findings on diagnostic imaging of lung

975

3212

3.04

215.03

1.2

25.04

8.18

u/ml

0.75

Abnormalities of breathing

1764

4614

2.31

201.60

1.3

1.2

32.54

7.76

u/ml

1.98

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1240

4539

2.59

200.59

1.2

21.34

8.60

u/ml

0.63

Pain in limb

1458

4405

2.44

197.20

1.3

1.2

3.78

17.35

u/ml

1.45

General symptoms and signs

2068

4903

2.14

189.50

1.3

1.2

7.23

20.41

u/ml

1.45

Diseases of the skin and subcutaneous tissue

1855

4217

2.24

188.35

1.3

1.2

13.97

9.28

u/ml

0.23

Examination and observation for other reasons

1109

2474

2.78

185.22

1.2

4.40

14.78

u/ml

0.88

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1825

6206

2.14

182.58

1.2

6.30

16.90

u/ml

1.21

Myalgia

575

1582

3.78

179.12

1.4

1.2

27.20

20.78

u/ml

—

Azathioprine

402

852

4.94

177.61

1.5

1.2

33.77

0.58

u/ml

—

Fever of other and unknown origin

1040

3721

2.65

176.21

1.2

1.49

23.59

u/ml

2.81

Diseases of oesophagus, stomach and duodenum

1958

5826

2.07

173.20

1.3

1.2

19.98

13.72

u/ml

0.31

Hypothyroidism, strict autoimmune

1210

3305

2.46

164.19

1.3

1.1

18.45

10.68

u/ml

0.30

Dyspnoea

1628

5938

2.14

163.80

1.3

1.2

24.14

11.97

u/ml

0.68

Soft tissue disorders

1844

4611

2.11

163.43

1.2

19.54

16.67

u/ml

0.12

Gastro-oesophageal reflux disease

1275

4976

2.31

160.41

1.3

1.2

9.54

10.06

u/ml

0.04

L04AA Selective immunosuppressants

572

1693

3.53

159.98

1.3

1.2

40.24

15.17

u/ml

0.98

Seropositive rheumatoid arthritis, wide

655

2142

3.17

155.20

1.2

12.73

9.97

u/ml

0.12

Other disorders of skin and subcutaneous tissue

1259

5143

2.29

155.12

1.3

1.2

13.81

12.65

u/ml

0.06

Other/unspecified seropositive rheumatoid arthritis

644

2118

3.16

151.11

1.2

13.76

9.97

u/ml

0.16

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

639

2094

3.17

150.92

1.2

13.46

9.66

u/ml

0.16

Headache

1208

4508

2.28

145.35

1.3

1.2

7.37

20.62

u/ml

1.28

Systemic sclerosis,strict definition

116

23.57

141.51

1.6

1.2

0.46

—

u/ml

—

Other (seronegative) rheumatoid arthritis, wide

496

1451

3.57

141.40

1.2

26.60

17.23

u/ml

—

Asthma, excluding more controls

1321

3183

2.24

137.77

1.2

25.50

3.56

u/ml

1.47

Asthma

1347

3329

2.20

134.50

1.2

24.48

3.48

u/ml

1.46

Asthma, unspecified (mode), excluding more controls

907

2909

2.49

131.60

1.2

35.31

0.72

u/ml

2.00

Dermatopolymyositis (FG)

104

21.45

130.96

1.7

1.1

50.04

—

u/ml

—

Other disorders of lacrimal gland

729

2776

2.71

130.03

1.3

1.2

12.71

15.34

u/ml

0.10

Asthma, unspecified (mode)

922

3034

2.45

129.48

1.2

35.31

0.71

u/ml

2.00

Asthma (mode)

1322

3382

2.18

129.45

1.2

24.48

3.48

u/ml

1.46

Sulfasalazine

561

1876

3.07

127.24

1.2

12.42

0.56

u/ml

—

Asthma (only as main-diagnosis), excluding more controls

1182

3183

2.24

127.23

1.2

28.31

3.56

u/ml

1.57

Anaemias

504

982

3.50

126.10

1.2

6.36

19.41

u/ml

—

Asthma (only as main-diagnosis)

1197

3329

2.20

123.36

1.2

28.31

3.48

u/ml

1.58

Dermatopolymyositis

108

17.08

121.17

1.7

1.1

50.04

—

u/ml

—

Dorsalgia

1705

4870

1.92

119.16

1.2

14.00

16.93

u/ml

0.13

Nerve, nerve root and plexus disorders

1801

6156

1.86

118.78

1.2

29.35

6.43

u/ml

2.04

General examination and investigation of persons without complaint and reported diagnosis

1059

2485

2.30

116.98

1.2

11.40

14.78

u/ml

—

Disorders of lacrimal system

820

3472

2.42

116.54

1.3

1.2

11.99

13.12

u/ml

0.04

Symptoms and signs involving the circulatory and respiratory systems

1740

4635

1.90

116.49

1.2

39.04

7.76

u/ml

1.76

Excluding asthma or asthma-COPD overlap

1366

3364

2.06

113.66

1.2

23.90

3.48

u/ml

1.09

Other pulmonary diagnosis

1366

3364

2.06

113.66

1.2

22.78

3.48

u/ml

1.07

Gonarthrosis [arthrosis of knee](FG)

1030

2714

2.26

112.99

1.2

1.1

0.52

2.80

u/ml

—

Pain in throat and chest

1413

4400

1.99

112.53

1.2

14.96

7.91

u/ml

0.26

Low back pain

1235

4740

2.04

110.29

1.3

1.2

11.36

15.83

u/ml

0.20

Diseases of arteries, arterioles and capillaries

1081

3823

2.15

109.85

1.3

1.2

13.87

9.39

u/ml

0.25

Cardiovascular diseases

1132

2892

2.16

108.99

1.2

33.87

14.87

u/ml

0.70

Arthrosis

1067

2686

2.21

108.96

1.2

4.84

17.89

u/ml

1.08

Tramadol

1349

4420

1.99

108.77

1.2

3.86

13.10

u/ml

1.37

Follow-up examination after treatment for conditions other than malignant neoplasms

781

2086

2.49

108.72

1.2

20.78

15.81

u/ml

—

Cough

740

2949

2.46

108.57

1.2

25.84

7.46

u/ml

0.88

Codeine

1636

4846

1.88

107.60

1.2

12.30

15.35

u/ml

0.15

Other and unspecified polyneuropathies, also in other diseases

381

1123

3.52

107.12

1.3

1.2

18.17

23.42

u/ml

—

Other dorsopathies, not elsewhere classified

1697

4886

1.85

106.23

1.2

8.90

16.93

u/ml

0.40

GASTRO-related operations

1392

3550

1.99

105.95

1.2

23.21

14.89

u/ml

0.27

Any gastric operation

1392

3550

1.99

105.95

1.2

23.21

14.89

u/ml

0.27

Urticaria and erythema

737

3114

2.42

105.28

1.3

1.2

0.66

16.33

u/ml

—

Any reimbursement code in KELA

1054

2416

2.22

105.12

1.3

1.2

17.48

14.25

u/ml

0.12

COPD differential diagnosis

1341

3382

2.01

104.72

1.2

23.90

3.48

u/ml

1.09

Myositis

116

11.22

104.62

1.6

1.2

39.60

—

u/ml

—

ILD differential diagnosis

1340

3382

2.01

104.42

1.2

23.90

3.48

u/ml

1.09

Polyneuropathies and other disorders of the peripheral nervous system

421

1348

3.23

103.41

1.3

1.2

15.69

21.34

u/ml

0.12

Other special examinations and investigations of persons without complaint or reported diagnosis

1058

2485

2.18

102.11

1.3

1.2

22.41

14.78

u/ml

—

Spondylopathies

1295

4064

1.96

99.13

1.2

4.64

11.79

u/ml

0.78

Seropositive rheumatoid arthritis, strict definition

369

1134

3.39

97.48

1.2

11.07

16.30

u/ml

—

Codeine or tramadol medication

1898

6120

1.74

97.14

1.2

11.90

15.63

u/ml

0.20

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1825

6008

1.75

96.78

1.3

1.2

29.87

9.77

u/ml

1.06

Disorders of eyelid, lacrimal system and orbit

1398

5972

1.86

96.50

1.3

1.2

8.82

16.24

u/ml

0.55

Other intervertebral disc disorders

1366

4456

1.90

95.63

1.2

15.78

14.69

u/ml

0.03

Bacterial infection, other or unspecified

842

3502

2.21

95.51

1.2

6.53

11.85

u/ml

0.36

Pain, not elsewhere classified

503

1873

2.75

93.63

1.3

1.2

9.95

18.99

u/ml

0.39

Other arthrosis

744

2302

2.35

93.21

1.2

7.06

17.52

u/ml

—

Neurological diseases

1460

3972

1.87

93.17

1.2

31.09

3.72

u/ml

1.88

Lower back pain or/and sciatica

1675

6709

1.75

92.73

1.3

1.2

8.52

16.41

u/ml

0.58

Opioids

1647

4899

1.78

91.36

1.2

19.77

15.15

u/ml

0.18

Symptoms and signs involving the skin and subcutaneous tissue

1154

6084

1.92

90.69

1.3

1.2

30.78

13.95

u/ml

—

Respiratory disorders in diseases classified elsewhere

12.55

89.23

1.7

1.2

44.35

—

u/ml

—

Shoulder lesions

1193

3808

1.94

89.22

1.2

5.91

16.42

u/ml

0.94

Abnormal findings on examination of blood, without diagnosis

738

3126

2.25

88.37

1.3

1.2

1.35

16.78

u/ml

—

Dorsopathies

1673

4911

1.76

87.54

1.2

11.37

16.93

u/ml

0.25

Pain (limb, back, neck, head abdominally)

1115

2815

2.00

86.92

1.2

0.49

16.40

u/ml

—

Certain infectious and parasitic diseases

1649

4751

1.76

85.83

1.2

15.30

15.71

u/ml

0.01

Methotrexate

299

878

3.52

84.58

1.2

4.07

0.58

u/ml

—

Persons encountering health services in other circumstances, wide

1915

6016

1.67

83.65

1.3

1.2

18.49

9.77

u/ml

0.50

Renal failure

629

2527

2.31

80.44

1.2

0.38

8.63

u/ml

—

Other diseases of pleura

671

2686

2.25

79.92

1.3

1.2

28.64

10.90

u/ml

0.87

Malaise and fatigue

751

2945

2.16

79.68

1.3

1.2

1.79

19.02

u/ml

1.80

Migraine

892

3820

2.02

79.41

1.3

1.2

7.82

13.55

u/ml

0.39

Episodal and paroxysmal disorders

1787

5534

1.67

78.41

1.2

18.45

13.43

u/ml

0.23

Gonarthrosis

879

2458

2.07

77.86

1.2

0.52

17.58

u/ml

—

Urticaria

579

2518

2.35

77.65

1.3

1.2

0.66

14.37

u/ml

—

Diseases of liver

591

2603

2.32

76.87

1.2

9.40

16.43

u/ml

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

290

906

3.31

74.46

1.3

1.2

5.40

10.40

u/ml

—

Asthma (diagnoses ohter than nonallergic)

1363

6859

1.72

73.43

1.2

22.42

11.94

u/ml

0.62

Other diseases of intestines

1674

5936

1.65

73.01

1.2

4.98

18.31

u/ml

1.95

Persons encountering health services for examination and investigation

969

2485

1.97

72.61

1.2

7.66

14.78

u/ml

—

Coxibs

428

816

2.83

71.89

1.2

0.62

1.24

u/ml

—

Other bacterial diseases

1411

5799

1.70

70.47

1.2

7.31

13.38

u/ml

0.59

Gastrointestinal diseases

983

2574

1.93

69.40

1.2

11.36

15.17

u/ml

0.17

1406

5227

1.70

69.34

1.2

11.14

16.94

u/ml

0.37

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1406

5227

1.70

69.34

1.2

11.14

16.94

u/ml

0.37

Certain disorders involving the immune mechanism

380

1437

2.72

69.11

1.2

13.36

22.98

u/ml

—

Other and unspecified urticaria

395

1523

2.67

69.05

1.3

1.2

0.72

16.35

u/ml

—

Hypothyroidism (congenital or acquired)

472

1063

2.59

68.82

1.3

1.2

8.36

15.16

u/ml

—

Parasetamol

1242

3597

1.78

68.19

1.2

32.90

16.84

u/ml

0.60

Hypothyroidism and >3 levothyroxin purchases

469

1060

2.59

68.10

1.3

1.2

8.36

15.16

u/ml

—

Hypothyroidism, levothyroxine purchases

469

1060

2.59

68.10

1.3

1.2

8.36

15.16

u/ml

—

Glomerular diseases

328

1162

2.90

67.54

1.2

0.36

19.60

u/ml

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

566

1214

2.36

65.93

1.2

10.80

8.97

u/ml

—

Osteopathies and chondropathies

858

4339

1.90

65.82

1.3

1.2

4.49

13.33

u/ml

0.84

Chronic laryngitis and laryngotracheitis

286

954

3.10

65.79

1.3

1.2

—

25.82

—

Other and unspecified disorders of skin and subcutaneous tissue

167

391

4.50

65.75

1.3

1.2

8.08

9.17

u/ml

—

Papulosquamous disorders

656

3210

2.08

65.36

1.2

11.61

14.79

u/ml

—

Cardiovascular diseases (excluding rheumatic etc)

1090

3516

1.81

65.18

1.2

28.47

18.20

u/ml

0.26

Coxarthrosis [arthrosis of hip](FG)

617

2095

2.15

63.84

1.2

1.1

2.66

4.11

u/ml

—

ILD and respiratory illness in diseases classified elsewhere

24.01

63.52

1.5

1.2

52.20

—

u/ml

—

Hypothyroidism, other/unspecified

1408

5668

1.66

63.34

1.3

1.2

16.87

13.87

u/ml

0.11

Asthma, including avohilmo

1791

6687

1.57

63.15

1.2

19.57

12.49

u/ml

0.42

Chronic lower respiratory diseases

1852

6474

1.56

62.71

1.2

20.95

12.16

u/ml

0.53

Other/unspecified dorsalgia

587

2788

2.13

62.28

1.2

0.36

15.75

u/ml

—

Diseases of salivary glands

365

1424

2.63

62.26

1.3

1.2

6.17

9.15

u/ml

0.15

Pneumonia, organism unspecified

1350

5965

1.65

61.35

1.2

8.84

17.22

u/ml

0.64

Spondylosis

782

3534

1.92

61.11

1.2

7.43

9.07

u/ml

—

Disorders of the thyroid gland

1464

5947

1.62

60.94

1.3

1.2

17.62

13.72

u/ml

0.14

Hypothyreosis and Thyroxine purchase for inclusion criteria

1444

5926

1.62

60.16

1.3

1.2

16.87

13.46

u/ml

0.13

Diseases of the respiratory system

1006

2785

1.83

60.09

1.2

23.64

6.42

u/ml

0.69

Other headache syndromes

712

3694

1.96

60.01

1.3

1.2

42.01

16.50

u/ml

—

Sleep disorders (combined)

1509

6220

1.61

59.89

1.2

7.17

15.45

u/ml

0.97

Influenza and pneumonia

1595

6684

1.58

59.81

1.2

9.82

15.68

u/ml

0.46

Atopic dermatitis

874

4099

1.84

59.76

1.3

1.2

18.09

17.98

u/ml

0.00

Diseases of the myoneural junction and muscle

237

751

3.27

59.62

1.4

1.2

2.10

11.36

u/ml

—

Hallux valgus (acquired)

484

1533

2.32

59.58

1.2

0.48

20.37

u/ml

—

Temporomandibular joint disorders

287

1014

2.90

59.30

1.3

1.2

11.20

9.32

u/ml

—

Meniscus derangement

708

2453

2.00

59.24

1.2

3.70

16.09

u/ml

—

Other heart diseases

794

2761

1.92

59.07

1.2

15.39

11.94

u/ml

0.13

Sciatica+with lumbago

772

3912

1.90

59.06

1.3

1.2

0.64

15.76

u/ml

2.49

Other diseases of upper respiratory tract

1653

5511

1.58

58.21

1.2

6.51

11.31

u/ml

0.43

Antihypertensive medication - note that there are other indications

1012

3121

1.79

58.02

1.2

14.91

19.60

u/ml

0.19

Heart failure, not strict

1080

4353

1.73

57.53

1.2

21.03

10.01

u/ml

0.44

Disorders of muscles

196

572

3.54

56.21

1.4

1.2

39.60

14.12

u/ml

—

Polymyositis

15.15

56.11

1.8

1.2

51.30

—

u/ml

—

Symptoms and signs involving the nervous and musculoskeletal systems

868

4893

1.80

56.06

1.3

1.2

27.77

11.79

u/ml

—

Other/unspecified rheumatoid arthritis

256

880

3.01

55.99

1.3

1.2

35.18

11.39

u/ml

—

Rotator cuff syndrome

852

3496

1.83

55.86

1.2

5.35

14.90

u/ml

0.70

COPD/asthma/ILD related infections

1626

5232

1.57

55.58

1.2

13.96

16.94

u/ml

0.14

COPD/asthma related infections

1626

5232

1.57

55.58

1.2

13.96

16.94

u/ml

0.14

Asthma, hospital admission 2, infections

861

4776

1.79

55.42

1.2

8.23

10.00

u/ml

0.11

Asthma-related infections

861

4776

1.79

55.42

1.2

8.23

10.00

u/ml

0.11

Diseases of pulp and periapical tissues

544

2643

2.09

55.26

1.2

5.07

12.89

u/ml

—

Lumbar disc prolapse

937

4263

1.77

55.22

1.2

20.10

15.78

u/ml

0.11

Disorders of skin appendages

756

4108

1.87

55.18

1.2

26.34

16.19

u/ml

0.27

Persons encountering health services for specific procedures and health care

1619

6526

1.55

54.81

1.2

5.45

15.42

u/ml

0.99

105

Other heart diseases, wide

1420

5573

1.59

54.43

1.2

10.50

17.55

u/ml

0.47

Pneumonias (Asthma/COPD co-morbidities)

1480

6586

1.57

54.25

1.2

11.13

15.68

u/ml

0.30

Oxicams

338

717

2.72

54.13

1.3

1.2

0.80

1.24

u/ml

—

Irritable bowel syndrome

486

2286

2.17

53.94

1.3

1.2

0.50

14.26

u/ml

—

Psoriasis

470

2184

2.19

53.82

1.2

13.45

17.86

u/ml

—

All pneumoniae

1487

6611

1.57

53.79

1.2

11.13

15.52

u/ml

0.28

Functional dyspepsia

443

2013

2.24

53.63

1.3

1.2

22.95

9.62

u/ml

—

Disorders of conjunctiva

1248

6537

1.61

53.00

1.3

1.2

8.50

16.27

u/ml

0.80

Asthma, hospital admissions , main diagnosis only

1237

6937

1.61

52.82

1.2

28.31

11.49

u/ml

0.91

100

Disorders of synovium and tendon

749

3701

1.84

52.08

1.3

1.2

6.63

20.01

u/ml

0.87

Chronic rhinitis, nasopharyngitis and pharyngitis

519

2537

2.08

51.97

1.2

3.70

16.54

u/ml

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1312

5653

1.60

51.64

1.3

1.2

17.63

13.78

u/ml

0.14

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1432

6501

1.56

51.33

1.2

11.13

15.57

u/ml

0.28

Nutritional anaemias

695

3677

1.86

50.47

1.2

5.86

9.70

u/ml

0.22

671

3586

1.88

50.37

1.2

1.26

8.02

u/ml

—

Neurotic, stress-related and somatoform disorders

1365

6243

1.57

50.05

1.2

20.36

14.67

u/ml

0.19

Other anaemias

563

2769

1.99

49.72

1.2

0.64

14.28

u/ml

—

Sleep apnoea, including avohilmo

1426

6002

1.56

49.59

1.2

7.13

17.37

u/ml

1.18

Anxiety disorders

1374

6287

1.56

49.58

1.2

20.36

14.67

u/ml

0.19

Anxiety disorders, excluding more controls

1285

5404

1.59

49.47

1.2

22.86

14.95

u/ml

0.25

Carpal tunnel syndrome

911

4854

1.71

49.33

1.3

1.2

37.77

6.85

u/ml

1.95

Other and unspecified anaemias

557

2745

1.99

49.31

1.2

0.64

14.28

u/ml

—

Dental caries

393

1744

2.27

49.10

1.3

1.2

4.96

13.92

u/ml

0.55

Coxarthrosis

584

2003

2.00

49.07

1.2

2.66

21.87

u/ml

—

Sleep apnoea

1339

5838

1.57

48.89

1.2

7.80

14.29

u/ml

0.63

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

759

2651

1.84

48.82

1.3

1.2

14.30

13.45

u/ml

—

21.22

48.69

1.5

1.2

52.20

—

u/ml

—

Coagulation defects, purpura and other haemorrhagic conditions

329

1387

2.43

47.69

1.3

1.2

1.27

7.26

u/ml

—

Obesity related asthma

527

2675

2.00

47.61

1.2

8.86

7.81

u/ml

—

Reactive arthropathies

153

424

3.72

47.47

1.2

12.86

26.31

u/ml

—

Chronic sinusitis

653

3555

1.86

47.46

1.2

3.68

14.89

u/ml

—

Aplastic and other anaemias

601

3014

1.92

47.45

1.2

0.64

13.51

u/ml

—

Dysphagia

372

1659

2.28

47.19

1.3

1.2

9.52

13.20

u/ml

—

Recurrent or chronic depression

676

2645

1.87

47.18

1.2

8.54

16.29

u/ml

—

1686

5996

1.50

47.12

1.2

7.06

16.51

u/ml

0.83

Diaphragmatic hernia

548

2832

1.97

46.96

1.3

1.2

11.27

13.57

u/ml

—

Implicit Sepsis

1010

4794

1.65

46.81

1.2

18.29

8.67

u/ml

0.37

Iron deficiency anaemia

598

3150

1.91

46.79

1.2

7.46

11.47

u/ml

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

11.53

46.65

1.5

1.3

—

Symptoms and signs involving the digestive system and abdomen

1460

4783

1.54

46.32

1.2

13.41

13.92

u/ml

0.02

Renal tubulo-interstitial diseases

1235

6084

1.57

46.20

1.2

1.95

18.10

u/ml

3.19

Depression

1429

6517

1.52

45.66

1.2

16.80

14.98

u/ml

0.06

Other antidepressants

1512

5227

1.52

45.57

1.2

4.87

15.11

u/ml

1.37

Somatoform disorder

307

1285

2.45

45.31

1.3

1.2

11.40

17.08

u/ml

—

Migraine with aura

415

1967

2.15

45.24

1.3

1.2

5.44

13.78

u/ml

0.49

Dentinal caries

346

1516

2.31

45.17

1.3

1.2

5.97

11.33

u/ml

—

Depression medications

468

1102

2.16

44.67

1.2

9.03

22.29

u/ml

—

Chronic gastritis

398

1865

2.17

44.63

1.2

3.19

10.07

u/ml

—

Conjunctivitis

1120

6214

1.59

44.57

1.2

8.00

17.07

u/ml

0.90

Diseases of the eye and adnexa

1242

3956

1.58

44.52

1.2

24.88

20.31

u/ml

0.13

Hypertensive diseases (excluding secondary)

834

2807

1.75

44.50

1.2

25.62

13.14

u/ml

—

Spinal stenosis

672

2916

1.83

44.39

1.3

1.2

1.93

11.89

u/ml

1.34

Other and unspecified iron deficiency

481

2425

2.01

44.25

1.2

9.50

15.01

u/ml

—

Disorders of sclera, cornea, iris and ciliary body

788

4630

1.72

44.19

1.2

10.30

13.56

u/ml

0.19

Abdominal and pelvic pain

1441

4782

1.53

43.82

1.2

13.42

13.92

u/ml

0.01

Mood [affective] disorders

1505

6686

1.49

43.42

1.2

14.33

14.70

u/ml

0.01

Mood disorders

1506

6697

1.49

42.94

1.2

14.34

14.70

u/ml

0.01

Impingement syndrome of shoulder

369

1706

2.20

42.88

1.2

2.80

20.62

u/ml

—

Complications of surgical and medical care, not elsewhere classified

1387

6673

1.50

42.05

1.2

16.85

13.29

u/ml

0.11

100

Chronic periapical parodontitis

325

1446

2.29

41.58

1.3

1.2

7.17

10.67

u/ml

—

Other enthesopathies

433

2160

2.03

41.09

1.3

1.2

17.07

18.72

u/ml

—

Hypothyroidism, drug reimbursement

257

717

2.61

40.59

1.3

1.2

32.00

21.51

u/ml

—

Mood disorders, excluding more controls

1394

5704

1.50

40.56

1.2

13.55

14.79

u/ml

0.04

Visual disturbances and blindness

718

4220

1.72

40.30

1.2

13.48

9.74

u/ml

—

Any operation in hilmo

9.29

40.13

1.2

1.1

—

Other diseases of hard tissues of teeth

907

4173

1.64

40.13

1.3

1.2

13.54

14.50

u/ml

0.05

Diverticular disease of intestine

962

3991

1.62

39.67

1.2

0.75

13.58

u/ml

—

Mycoses

403

1987

2.06

39.65

1.3

1.2

11.54

18.08

u/ml

—

Noninfective enteritis and colitis

668

3864

1.75

39.53

1.2

31.97

17.19

u/ml

—

Infections of the skin and subcutaneous tissue

790

4788

1.66

38.73

1.3

1.2

5.27

19.37

u/ml

1.35

Other symptoms and signs involving the nervous and musculoskeletal systems

616

3510

1.78

38.67

1.3

1.2

49.00

13.02

u/ml

—

All anxiety disorders

916

4646

1.60

37.76

1.2

17.81

17.17

u/ml

0.01

Endocrine, nutritional and metabolic diseases

1206

4031

1.53

37.74

1.2

8.36

17.28

u/ml

0.65

Acute upper respiratory infections

1484

6434

1.45

37.55

1.2

6.77

15.79

u/ml

0.67

Polycystic ovarian syndrome, consortium definition

1158

4604

1.53

37.24

1.3

1.2

5.05

15.48

u/ml

1.32

Codes for special purposes

643

3750

1.73

37.16

1.3

1.2

10.24

18.49

u/ml

—

Depression or dysthymia

1041

3739

1.57

36.97

1.2

0.64

14.96

u/ml

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1344

5985

1.47

36.48

1.3

1.2

9.36

16.06

u/ml

0.39

Provisional assignment of new diseases of uncertain etiology

640

3748

1.73

36.45

1.3

1.2

10.24

18.49

u/ml

—

Hypertension, essential

1134

4255

1.53

36.33

1.2

29.58

10.55

u/ml

0.63

Artrosis, including avohilmo

1176

4270

1.52

36.23

1.2

15.56

12.42

u/ml

0.11

Diseases of the ear and mastoid process

1706

6123

1.42

36.20

1.2

1.98

17.31

u/ml

3.30

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

701

4125

1.68

36.06

1.2

44.46

13.35

u/ml

—

Condition for Implicit Sepsis (Organ dysfunction codes)

1143

5531

1.51

36.05

1.2

14.75

12.08

u/ml

0.10

Osteoporosis

358

1665

2.09

36.03

1.3

1.2

8.29

11.86

u/ml

—

Other disorders of teeth and supporting structures

319

1496

2.17

35.89

1.3

1.2

4.20

10.64

u/ml

—

Dentofacial anomalies [including malocclusion]

434

2247

1.94

35.87

1.3

1.2

14.19

17.79

u/ml

—

Heart failure,strict

642

2685

1.74

35.87

1.2

6.66

9.57

u/ml

—

Visual disturbances

662

3932

1.70

35.84

1.2

16.49

11.09

u/ml

—

Triptan medication for migraine, single purchase ok

1168

5287

1.51

35.80

1.2

5.61

16.75

u/ml

1.22

Migraine, single triptan purchase ok & required. ICD-code if available is included

1168

5287

1.51

35.80

1.2

5.61

16.75

u/ml

1.22

Anxiety (asthma-related co-morbidities)

902

4525

1.59

35.60

1.2

17.81

18.25

u/ml

0.01

Cardiac arrhythmias

941

3973

1.58

35.37

1.2

4.18

17.60

u/ml

—

Migraine with aura and triptan purchases

278

1248

2.28

35.02

1.3

1.2

0.64

19.49

u/ml

—

Other and unspecified coagulation defects

115

326

3.69

34.91

1.2

—

9.08

—

Migraine without aura

333

1606

2.11

34.86

1.3

1.2

11.03

9.95

u/ml

—

Heart failure and antihypertensive medication

357

1132

2.11

34.66

1.2

11.68

13.53

u/ml

—

Persons encountering health services in other circumstances

533

3009

1.79

34.50

1.4

1.2

10.30

11.72

u/ml

0.07

Fibrosis and cirrhosis of liver

142

462

3.19

34.48

1.3

1.2

—

10.98

—

Concussion

641

3279

1.71

34.41

1.2

0.63

4.56

u/ml

—

Diseases of oral cavity, salivary glands and jaws

1252

4340

1.49

34.40

1.2

17.86

13.62

u/ml

0.14

Asthma, hospital admissions 3, pneumonia

469

2550

1.86

34.32

1.2

14.10

6.09

u/ml

—

Asthma-related pneumonia or sepsis

469

2550

1.86

34.32

1.2

14.10

6.09

u/ml

—

Diagnoses used for exclusion with ILD

355

1767

2.04

34.06

1.2

17.81

17.35

u/ml

—

Bacterial Sepsis

552

2803

1.77

33.84

1.2

9.83

9.12

u/ml

—

Unspecified urinary incontinence

163

579

2.90

33.81

1.3

1.2

—

9.12

—

Asthma-related pneumonia

466

2541

1.85

33.80

1.2

14.10

6.09

u/ml

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1338

6527

1.45

33.61

1.2

13.35

14.80

u/ml

0.05

Primary biliary cholangitis (PBC)

101

6.23

33.51

1.5

1.1

—

Symptoms and signs involving the urinary system

1001

5105

1.53

33.46

1.2

2.99

12.46

u/ml

—

Implicit bacterial Sepsis

482

2436

1.84

33.42

1.2

9.83

10.90

u/ml

—

Spondyloarthritis

250

1097

2.32

33.09

1.3

1.2

0.45

6.95

u/ml

—

Metabolic disorders

1297

5580

1.45

32.77

1.2

10.54

11.19

u/ml

0.04

Asthma/COPD (KELA code 203)

1312

6445

1.44

32.73

1.2

15.07

12.16

u/ml

0.15

Chronic diseases of tonsils and adenoids

1131

4837

1.49

32.55

1.2

29.12

12.52

u/ml

0.56

Atopic dermatitis, strict definition with reimbursement

433

2266

1.88

32.46

1.3

1.2

20.53

22.87

u/ml

—

Hypertensive diseases

1143

4367

1.49

32.33

1.2

29.58

10.07

u/ml

0.66

Bronchitis

1478

6903

1.41

32.31

1.2

2.70

17.65

u/ml

3.08

Cystitis

1240

5222

1.46

32.16

1.2

17.44

12.40

u/ml

0.19

Other coagulation defects

143

487

3.04

32.09

1.2

—

6.97

—

Exposure to unspecified factor

1323

7218

1.43

31.98

1.2

4.00

15.49

u/ml

2.08

109

Viral infections characterized by skin and mucous membrane lesions

568

3343

1.72

31.79

1.2

42.78

10.17

u/ml

—

Hypertension

1139

4364

1.49

31.75

1.2

29.58

10.07

u/ml

0.66

Other functional intestinal disorders

585

3304

1.70

31.61

1.2

3.78

13.09

u/ml

—

Acute upper respiratory infections of multiple and unspecified sites

1029

5199

1.49

30.84

1.2

0.84

17.84

u/ml

3.56

Disorders of other endocrine glands

603

3595

1.67

30.25

1.3

1.2

0.70

15.63

u/ml

—

Other gastritis (incl. Duodenitis)

305

1502

2.06

30.21

1.3

1.2

46.67

11.38

u/ml

—

Other anxiety disorders

655

3583

1.64

30.11

1.2

2.43

18.29

u/ml

—

Intracranial trauma

727

3428

1.60

29.48

1.2

0.75

4.07

u/ml

—

Dizziness and giddiness

1003

5545

1.48

29.04

1.2

3.58

11.12

u/ml

1.08

Septicaemia

486

2699

1.75

29.04

1.3

1.2

2.64

11.05

u/ml

0.67

Menorrhagia

571

1855

1.72

29.01

1.3

1.2

0.40

20.79

u/ml

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

794

5099

1.55

28.99

1.2

8.21

19.67

u/ml

0.80

Complications of medical and surgical care

971

6276

1.48

28.84

1.2

8.92

14.10

u/ml

—

Syncope and collapse

527

2755

1.71

28.74

1.3

1.2

0.49

20.19

u/ml

—

Triptan medication for migraine, min. 3 purchases

855

4463

1.53

28.55

1.2

4.98

17.63

u/ml

1.22

Other disorders of urethra and urinary system

974

4950

1.49

28.47

1.2

10.68

12.87

u/ml

0.08

Nausea and vomiting

354

1841

1.91

28.43

1.3

1.2

13.68

13.20

u/ml

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1299

6308

1.41

28.15

1.2

4.50

16.99

u/ml

1.94

Heart failure, strict

663

2980

1.62

28.02

1.2

6.18

12.39

u/ml

—

Other diseases of urinary system

1426

5804

1.39

27.77

1.2

20.28

13.13

u/ml

0.28

Other arrhythmias

860

4381

1.51

27.73

1.2

2.74

13.00

u/ml

1.57

Purpura and other haemorrhagic conditions

202

877

2.35

27.65

1.4

1.2

1.27

5.72

u/ml

—

Other septicaemia

430

2393

1.78

27.52

1.3

1.2

2.85

12.53

u/ml

0.69

All-cause Heart Failure

651

2932

1.61

27.43

1.2

6.18

12.39

u/ml

—

Complications of procedures, not elsewhere classified

1070

6472

1.44

27.10

1.2

3.89

12.60

u/ml

1.20

Gingivitis and periodontal diseases

1195

4333

1.43

27.08

1.2

20.62

13.62

u/ml

0.20

Explicit Sepsis

522

3021

1.67

26.53

1.3

1.2

3.30

8.12

u/ml

0.48

Excessive, frequent and irregular menstruation

619

2122

1.64

26.32

1.3

1.2

6.94

20.24

u/ml

—

Venous thromboembolism

672

4209

1.56

25.97

1.2

5.63

13.41

u/ml

0.71

Gonarthrosis,primary

1148

5113

1.42

25.92

1.2

4.53

12.01

u/ml

0.77

Allergic conjunctivitis

817

5425

1.50

25.66

1.2

7.57

18.07

u/ml

0.80

Pure hypercholesterolaemia

913

4175

1.48

25.60

1.2

17.87

12.13

u/ml

0.30

Iridocyclitis

322

1714

1.91

25.58

1.2

6.36

22.80

u/ml

—

Other diseases of blood and blood-forming organs, wide

308

1629

1.92

24.99

1.2

2.18

19.77

u/ml

—

Care involving use of rehabilitation procedures

834

5401

1.48

24.64

1.2

10.06

13.11

u/ml

0.17

Crystal arthropathies, rheuma endpoint

6.86

24.54

1.4

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

387

2207

1.77

24.47

1.3

1.2

7.96

14.96

u/ml

—

Irregular menses

741

3995

1.52

24.45

1.3

1.2

6.18

17.50

u/ml

1.00

DVT of lower extremities and pulmonary embolism

507

3100

1.65

24.41

1.2

6.04

13.89

u/ml

0.52

Thyroiditis, ILD-related definition

177

768

2.35

24.33

1.3

1.2

13.12

6.95

u/ml

—

Temporomandibular joint disorders, including avohilmo

614

3944

1.57

24.26

1.3

1.2

7.26

17.07

u/ml

—

Allergic asthma (mode), excluding more controls

309

1619

1.89

24.17

1.2

0.40

6.64

u/ml

—

Other abnormal uterine and vaginal bleeding

353

1379

1.85

24.16

1.3

1.2

0.74

15.89

u/ml

—

Acute sinusitis

708

4372

1.52

24.14

1.2

6.62

20.61

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

744

4491

1.51

24.11

1.2

11.90

12.88

u/ml

—

Deforming dorsopathies

368

2080

1.79

24.03

1.3

1.2

9.08

10.45

u/ml

—

Polyarteritis nodosa and related conditions

6.37

23.77

1.3

1.2

—

Non-selective monoamine reuptake inhibitors

521

3140

1.63

23.75

1.2

8.91

10.19

u/ml

—

Disorders of lipoprotein metabolism and other lipidaemias

1034

4600

1.42

23.50

1.2

12.59

10.73

u/ml

0.10

Behçet disease

20.71

23.46

1.3

1.4

—

Other nutritional deficiencies

879

5992

1.44

23.23

1.2

12.50

15.13

u/ml

0.11

Other/unspecified reactive arthropathies

121

450

2.77

23.19

1.2

12.86

10.92

u/ml

—

Allergic asthma (mode)

309

1645

1.86

23.03

1.2

0.40

6.63

u/ml

—

Constipation

1128

5849

1.39

22.97

1.2

2.22

11.83

u/ml

2.06

Cerebrovascular diseases (FINNGEN)

426

1790

1.72

22.96

1.2

8.96

13.95

u/ml

—

Dialysis, with operation codes

173

764

2.31

22.84

1.2

—

6.99

—

Coeliac disease

194

901

2.20

22.69

1.4

1.2

26.60

9.55

u/ml

—

Migraine without aura and triptan purchases

258

1334

1.97

22.49

1.3

1.2

11.03

18.59

u/ml

—

Lichen ruber planus, wide definition including periferal and oral lichen planus

304

1661

1.86

22.38

1.2

0.42

14.70

u/ml

—

Diseases of the digestive system

544

3467

1.58

22.15

1.3

1.2

26.60

12.67

u/ml

—

Cellulitis

282

1516

1.89

21.80

1.3

1.2

0.87

20.70

u/ml

—

Valvular heart disease excluding rheumatic fever

555

2583

1.58

21.80

1.3

1.2

9.70

15.19

u/ml

0.28

Non-rheumatic valve diseases

553

2571

1.58

21.72

1.3

1.2

9.70

15.19

u/ml

0.28

Benign neoplasm: Colon

611

3967

1.52

21.01

1.2

11.90

12.35

u/ml

—

TMD related operations

257

1359

1.92

21.01

1.3

1.2

10.50

18.87

u/ml

—

Care involving dialysis

117

451

2.66

20.88

1.3

1.2

—

0.60

—

Other reaction to severe stress, and adjustment disorders

510

3258

1.58

20.86

1.3

1.2

10.62

17.42

u/ml

0.32

Preparatory care for dialysis

247

3.32

20.72

1.3

1.1

—

Atopic dermatitis, strict definition

419

2510

1.65

20.57

1.3

1.2

20.53

14.90

u/ml

—

Genitourinary diseases

743

2520

1.49

20.50

1.2

21.78

19.75

u/ml

—

Benign neoplasm of colon, rectum, anus and anal canal

710

3453

1.48

20.45

1.2

11.90

16.76

u/ml

—

Diarrhoea and gastroenteritis of presumed infectious origin

885

5739

1.41

20.40

1.2

0.91

17.29

u/ml

3.62

Psychiatric diseases

1497

5716

1.32

20.37

1.2

2.82

15.12

u/ml

2.21

Exposure to other specified factors

944

6394

1.39

20.37

1.2

21.39

14.66

u/ml

0.19

Keratitis

450

2812

1.62

20.25

1.3

1.2

13.96

15.43

u/ml

—

ILD medications: nintedanib

12.27

20.11

1.2

1.1

—

Ovarian cyst

549

2038

1.57

20.07

1.2

0.54

21.72

u/ml

—

Selective serotonin reuptake inhibitors

1326

5252

1.34

20.01

1.2

11.91

15.11

u/ml

0.12

Other crystal arthropathies

5.55

19.90

1.4

1.2

—

Anterior Iridocyclitis

280

1549

1.83

19.83

1.2

9.33

20.73

u/ml

—

Other disorders of ear

1170

5812

1.35

19.64

1.2

4.70

11.07

u/ml

0.76

Any mental disorder

1511

5808

1.31

19.60

1.2

3.03

14.79

u/ml

2.01

Acute and subacute iridocyclitis

262

1437

1.85

19.11

1.2

9.33

21.80

u/ml

—

Endometriosis

518

1980

1.57

19.01

1.3

1.2

0.66

21.72

u/ml

—

Intestinal infectious diseases

1191

6988

1.33

19.00

1.2

9.62

14.93

u/ml

0.24

Other acute lower respiratory infections

634

4124

1.48

18.97

1.2

4.84

16.18

u/ml

1.09

Benign neoplasms

1289

5448

1.33

18.90

1.2

21.91

13.13

u/ml

0.28

Oxycodone

395

2352

1.64

18.80

1.3

1.2

1.12

9.06

u/ml

—

Missing teeth due to accident, extraction or parodontitis

162

762

2.17

18.44

1.4

1.2

4.20

17.82

u/ml

—

Conjunctivitis (acute, non atopic)

365

2214

1.66

18.35

1.2

7.78

22.18

u/ml

—

Inflammatory diseases of female pelvic organs

894

4895

1.39

18.20

1.3

1.2

0.43

14.61

u/ml

—

Obesity due to excess calories

612

4190

1.47

18.12

1.2

14.16

17.99

u/ml

—

Cervicobrachial syndrome

289

1660

1.76

18.03

1.2

0.38

10.89

u/ml

—

Benign neoplasm: Colon

610

3178

1.48

17.99

1.2

11.90

17.01

u/ml

—

Benzodiazepine use

1282

7002

1.31

17.80

1.2

12.44

15.10

u/ml

0.10

Presence of other devices

257

1432

1.81

17.74

1.2

1.20

7.67

u/ml

—

Injuries to the ankle and foot

892

5949

1.37

17.74

1.2

12.84

16.32

u/ml

0.16

Diseases of external ear

411

2604

1.59

17.55

1.2

14.56

16.64

u/ml

—

Preparation and fitting of bite rail to mouth

208

1092

1.94

17.50

1.3

1.2

14.52

27.20

u/ml

—

Generalized anxiety disorder

217

1157

1.90

17.36

1.2

32.48

17.40

u/ml

—

Disorders of lens

830

3773

1.40

17.21

1.3

1.2

18.39

12.91

u/ml

0.19

Pain in thoracic spine

203

1065

1.93

17.07

1.3

1.2

10.56

8.25

u/ml

—

Obesity and other hyperalimentation

810

5830

1.38

17.04

1.2

13.85

14.86

u/ml

0.04

Dental operations

805

2949

1.41

16.92

1.2

12.44

11.27

u/ml

—

Obesity

805

5803

1.38

16.86

1.2

13.85

14.86

u/ml

0.04

Covid-19 suspected case

290

1701

1.73

16.85

1.3

1.2

11.68

15.44

u/ml

—

STROKE

724

3561

1.42

16.82

1.2

23.32

9.37

u/ml

0.41

All influenza

286

1672

1.73

16.76

1.3

1.2

0.77

12.81

u/ml

—

Bleeding

965

5232

1.35

16.58

1.2

6.08

12.32

u/ml

0.60

Acute bronchitis

478

3105

1.52

16.57

1.3

1.2

5.46

15.05

u/ml

—

Haemorrhoids and perianal venous thrombosis

338

2073

1.64

16.48

1.2

4.50

14.42

u/ml

—

Dermatographic urticaria

109

457

2.44

16.43

1.1

1.2

—

7.93

—

Presence of cardiac and vascular implants and grafts

462

2286

1.54

16.43

1.2

1.94

17.91

u/ml

—

Erysipelas

599

3788

1.45

16.41

1.2

12.22

11.10

u/ml

—

Other viral diseases

374

2350

1.60

16.38

1.3

1.2

15.25

25.12

u/ml

—

Dental caries 1 and operation codes

1110

4304

1.33

16.29

1.2

24.65

9.39

u/ml

0.46

Nephropathy related operations

154

748

2.09

16.17

1.3

1.2

—

6.99

—

Other specific arthropathies, wide

4.55

16.05

1.3

1.1

—

Erythema multiforme

138

3.79

16.00

1.6

1.1

—

Pulmonary embolism

328

2015

1.64

15.95

1.3

1.2

7.96

17.36

u/ml

—

Scleritis and episcleritis

102

422

2.48

15.87

1.2

—

10.92

—

Benign neoplasms

1038

4431

1.33

15.76

1.2

23.45

14.88

u/ml

0.25

Infections with a predominantly sexual mode of transmission

414

2694

1.55

15.72

1.3

1.2

0.95

20.58

u/ml

—

Acute tubulo-interstitial nephritis

731

4688

1.39

15.72

1.2

2.21

15.87

u/ml

2.06

Parodontitis or operation codes

1114

6301

1.31

15.59

1.2

5.91

12.43

u/ml

0.86

Pulmonary heart disease

328

2030

1.63

15.49

1.3

1.2

7.96

17.36

u/ml

—

Parodontitis

1112

6302

1.31

15.44

1.2

5.91

12.43

u/ml

0.86

Hernia

1159

6070

1.30

15.38

1.2

14.64

14.01

u/ml

0.03

Presence of other functional implants

642

3211

1.42

15.33

1.2

8.62

15.23

u/ml

—

Injuries to the knee and lower leg

1526

6957

1.26

15.31

1.2

20.09

12.98

u/ml

0.28

105

Chronic periodontitis, including avohilmo

1106

6299

1.31

15.24

1.2

5.91

11.95

u/ml

0.77

Other cataract

503

2639

1.49

15.21

1.2

9.53

13.91

u/ml

—

Secondary hypertension

100

416

2.42

14.95

1.3

1.2

—

29.19

—

Correction of physiology of bite - demanding therapy visit

117

529

2.26

14.87

1.5

1.2

10.50

9.17

u/ml

—

Diseases of pulp and periapical tissues, including avohilmo

1406

5779

1.27

14.67

1.2

16.74

12.73

u/ml

0.13

Dental pulpitis 4

1407

5786

1.27

14.61

1.2

16.74

12.73

u/ml

0.13

Dental pulpitis 1

1406

5786

1.27

14.55

1.2

16.74

12.73

u/ml

0.13

Diseases of inner ear

640

4508

1.40

14.46

1.2

3.76

12.72

u/ml

—

Dental caries 3 and operation codes

1149

4558

1.30

14.39

1.2

22.84

8.59

u/ml

0.47

Dental caries 2

1002

6037

1.31

14.39

1.2

37.90

11.15

u/ml

1.13

Disorders of gallbladder, biliary tract and pancreas

1237

6259

1.28

14.32

1.2

8.01

14.76

u/ml

0.39

Substance use, excluding alcohol

246

1452

1.71

14.06

1.2

1.06

20.69

u/ml

—

Disorders of vestibular function (Vertigo)

548

3837

1.43

13.99

1.2

4.30

12.15

u/ml

—

Pain associated with micturition

156

806

1.97

13.87

1.2

—

10.36

—

Neoplasms

1024

4205

1.31

13.87

1.2

9.96

15.16

u/ml

0.32

Other respiratory disorders and diseases

214

1220

1.77

13.84

1.2

14.46

9.55

u/ml

—

Other diseases of the respiratory system

214

1220

1.77

13.84

1.2

14.46

9.55

u/ml

—

Falls/tendency to fall

1482

5949

1.25

13.78

1.2

20.29

13.68

u/ml

0.23

Disorders of parathyroid gland

250

1476

1.69

13.62

1.2

0.88

14.75

u/ml

—

Fibroblastic disorders

245

1460

1.69

13.50

1.2

0.40

21.82

u/ml

—

Arthropathy in ulcerative colitis

4.45

13.40

1.1

1.2

—

Disorders of choroid and retina

914

5090

1.31

13.27

1.2

6.29

13.86

u/ml

0.75

Microscopic polyangiitis

6.78

13.25

1.5

1.3

—

Parodontitis and operation codes

1035

6269

1.29

13.18

1.2

5.91

12.09

u/ml

0.79

Artificial joint operation, meniscal resection

1069

5563

1.28

12.91

1.2

21.85

10.94

u/ml

0.29

Excessive attrition of teeth

499

1872

1.46

12.89

1.2

15.67

15.72

u/ml

—

Hyperlipidaemia, other/unspecified

410

2631

1.49

12.83

1.2

15.49

13.01

u/ml

—

Dental caries 2 and operation codes

973

6004

1.29

12.77

1.2

37.90

11.27

u/ml

1.12

TMD muscular pain linked with fibromyalgia

4.65

12.70

1.5

1.2

—

Non-allergic asthma (mode), excluding more controls

207

1187

1.74

12.70

1.2

0.58

0.56

u/ml

—

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1682

0.42

12.49

1.3

1.2

—

19.77

—

Biological medicines for asthma

4.02

12.41

1.1

1.2

—

Senile cataract

719

3316

1.35

12.41

1.2

18.48

11.55

u/ml

0.19

Type 2 diabetes, wide definition

943

4756

1.30

12.37

1.2

14.75

10.84

u/ml

0.22

Gonarthrosis, primary, with knee surgery

611

3655

1.37

12.19

1.2

7.76

15.28

u/ml

—

Use of hypnotics and sedatives

1345

6277

1.24

12.17

1.2

4.72

15.54

u/ml

1.24

Non-allergic asthma (mode)

207

1202

1.72

12.17

1.2

0.58

0.59

u/ml

—

Pulmonary eosinophilia, not elsewhere classified

4.64

12.10

1.0

1.1

—

Other diseases of anus and rectum

325

2137

1.53

11.89

1.2

0.78

17.20

u/ml

—

Dental caries 2, only avohilmo

967

5975

1.28

11.89

1.2

38.52

11.38

u/ml

1.07

Viral pneumonia

147

786

1.89

11.84

1.2

—

9.15

—

Primary gonarthrosis, bilateral

562

3586

1.38

11.65

1.2

7.91

14.97

u/ml

—

Varicose veins

749

4301

1.32

11.56

1.3

1.2

1.16

11.71

u/ml

—

Sensorineural hearing loss

857

4638

1.30

11.49

1.2

5.14

13.59

u/ml

0.82

Dental operations, only avohilmo

828

3241

1.31

11.46

1.2

10.27

11.03

u/ml

0.03

Conductive and sensorineural hearing loss

908

4902

1.29

11.41

1.2

4.99

12.86

u/ml

0.84

Diseases of middle ear and mastoid

692

4275

1.33

11.39

1.2

1.37

22.06

u/ml

—

Post-traumatic stress disorder

115

574

2.04

11.38

1.1

1.2

—

6.89

—

Dental pulpitis 4, only avohilmo

1408

5997

1.23

11.35

1.2

17.06

12.59

u/ml

0.15

Ischaemic heart disease, wide definition

882

4283

1.29

11.32

1.3

1.2

21.49

11.91

u/ml

0.24

Other viral diseases, not elsewhere classified

226

1382

1.65

11.28

1.3

1.2

18.20

7.75

u/ml

—

Ischemic heart diseases

895

4362

1.29

11.23

1.3

1.2

19.72

12.18

u/ml

0.20

Disorders of vitreous body and globe

565

4065

1.36

11.09

1.2

13.50

11.96

u/ml

0.07

Lesion of ulnar nerve

161

906

1.80

11.03

1.3

1.2

0.42

6.20

u/ml

—

Accidents

1107

4420

1.26

10.96

1.2

21.74

12.90

u/ml

0.25

Orthopaedic devices associated with adverse incidents

109

3.56

10.88

1.2

—

Injury, poisoning and certain other consequences of external causes

757

2886

1.32

10.81

1.2

9.93

9.79

u/ml

—

Other external causes of accidental injury

1105

4420

1.26

10.78

1.2

21.73

12.90

u/ml

0.25

Disorders of vitreous body

552

3991

1.36

10.77

1.2

13.50

12.44

u/ml

0.05

Unspecified fall

534

3896

1.37

10.72

1.2

0.62

14.30

u/ml

—

Fall on same level

1466

6761

1.22

10.68

1.2

20.56

13.60

u/ml

0.27

External causes of morbidity and mortality

912

3571

1.28

10.65

1.2

22.50

10.97

u/ml

—

Collagenous colitis

116

596

1.98

10.63

1.2

—

9.15

—

Ganglion

237

1499

1.59

10.44

1.2

0.70

24.40

u/ml

—

Dental pulpitis 1, only avohilmo

1402

6024

1.22

10.44

1.2

18.16

12.33

u/ml

0.19

Other conditions related to polyarteritis nodosa

12.45

10.37

1.3

—

Eosinophilic disease (BM)

3.95

10.34

1.3

1.1

—

Other retinal disorders

662

4043

1.32

10.34

1.3

1.2

3.48

14.61

u/ml

1.25

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

445

3197

1.40

10.26

1.2

14.72

20.81

u/ml

—

Episcleritis

350

2.28

10.25

1.2

—

10.92

—

Intracranial injury

627

4607

1.32

10.02

1.2

0.75

15.70

u/ml

—

Cholelithiasis

1026

5789

1.25

9.99

1.2

9.49

13.23

u/ml

0.16

Other/unspecified enthesopathies of lower limb, excluding foot

465

2.08

9.99

1.2

—

18.60

—

Mononeuritis multiplex

8.39

9.96

1.1

1.0

—

Dental caries 3

1010

4125

1.26

9.90

1.2

21.30

9.66

u/ml

0.39

Cholelithiasis, broad definition with cholecystitis

1058

5861

1.24

9.84

1.2

9.49

13.23

u/ml

0.16

Cholangitis (primary sclerosing, PSC), with reimbursement 202

3.60

9.73

1.2

1.1

—

Certolizumab pegol

102

3.47

9.72

1.2

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

416

2.12

9.70

1.2

—

0.58

—

Infective dermatitis

130

715

1.84

9.68

1.3

1.2

—

9.54

—

Hard cardiovascular diseases

887

4517

1.27

9.64

1.3

1.2

10.14

14.54

u/ml

0.24

Radial styloid tenosynovitis [de Quervain]

359

2.21

9.64

1.1

1.2

—

22.24

—

Trigger finger

160

938

1.72

9.57

1.4

1.2

0.59

19.49

u/ml

—

Molar incisor enamel hypoplasia, with caries

5.76

9.54

1.1

1.4

—

Postmenopausal atrophic vaginitis

325

1330

1.48

9.52

1.2

14.10

18.55

u/ml

—

394

2646

1.41

9.49

1.3

1.2

9.30

12.44

u/ml

—

COPD

432

2577

1.39

9.44

1.2

7.60

6.06

u/ml

—

Dental caries, including avohilmo

939

3828

1.26

9.40

1.2

17.90

10.72

u/ml

0.20

Other abnormalities of plasma proteins

3.69

9.37

1.3

1.2

—

Other neurological diseases

791

5019

1.27

9.33

1.2

16.57

8.38

u/ml

0.33

Dental pulpitis 2

841

3393

1.27

9.32

1.2

5.58

11.18

u/ml

—

Dental caries 1

938

3834

1.25

9.18

1.2

17.90

10.72

u/ml

0.20

Selective deficiency of immunoglobulin G [IgG] subclasses

4.51

9.13

1.4

1.3

—

Multifocal fibrosclerosis

5.85

9.12

1.1

1.2

—

Polyarteritis nodosa

5.81

9.10

1.2

—

Transplanted organ and tissue status

113

609

1.88

9.02

1.2

—

7.89

—

Hypoplasia of dental enamel, including avohilmo

5.42

9.00

1.1

1.3

—

Injuries to the thorax

455

3360

1.36

8.99

1.2

26.91

10.92

u/ml

—

Noninflammatory disorders of female genital tract

573

2171

1.34

8.93

1.3

1.2

8.98

19.78

u/ml

—

Fissure and fistula of anal and rectal regions

275

1863

1.49

8.92

1.3

1.2

11.70

19.24

u/ml

—

Degeneration of macula and posterior pole

450

2730

1.37

8.90

1.3

1.2

4.21

16.58

u/ml

0.82

Injuries to the wrist and hand

1197

7185

1.21

8.90

1.2

29.35

11.74

u/ml

0.63

101

Diseases of spleen

103

3.33

8.89

1.3

1.2

—

Ethmoidectomy

162

980

1.67

8.69

1.2

—

20.78

—

Dental caries 3, only avohilmo

1021

4242

1.24

8.69

1.2

21.30

9.52

u/ml

0.40

Moderate visual impairment, binocular

142

2.88

8.60

1.2

1.1

—

Persons encountering health services for specific procedures, not carried out

479

1.97

8.54

1.1

1.2

—

0.64

—

Dental pulpitis 2, only avohilmo

853

3484

1.26

8.54

1.2

4.72

11.18

u/ml

0.53

Phobic anxiety disorders

157

947

1.67

8.49

1.1

1.2

—

14.57

—

Other extrapyramidal and movement disorders in other diseases

250

1681

1.50

8.46

1.3

1.2

6.95

12.46

u/ml

—

Direct fill therapy

157

950

1.67

8.41

1.3

1.2

9.38

11.37

u/ml

—

FESS (DNB20)

156

945

1.67

8.35

1.2

—

9.54

—

Obsessive-compulsive disorder

388

2.06

8.29

1.3

1.2

—

10.82

—

Deficiency of other B group vitamins

124

2.99

8.22

1.1

1.2

—

Disorders of mineral metabolism

516

1.91

8.12

1.3

1.2

—

7.02

—

Tonsillectomy and adenotomy

699

3849

1.27

8.06

1.3

1.2

39.32

17.51

u/ml

0.49

Disorders of oesophagus in diseases classified elsewhere

110

3.10

7.98

1.3

1.2

—

Other and unspecified disorders of vitreous body

456

3421

1.33

7.93

1.2

14.51

15.06

u/ml

0.02

Female genital prolapse

376

1569

1.39

7.91

1.3

1.2

21.46

20.12

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

238

1608

1.49

7.89

1.3

1.2

1.68

13.21

u/ml

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

538

4118

1.30

7.88

1.2

30.18

14.50

u/ml

—

Fracture of foot, except ankle

271

1883

1.45

7.78

1.2

13.22

18.10

u/ml

—

Use of other anti-dementia drugs

1135

0.49

7.78

1.1

1.2

—

0.69

—

Use of memantine

1135

0.49

7.78

1.1

1.2

—

0.69

—

Dementia in Alzheimer disease

756

0.38

7.76

1.1

1.2

—

0.79

—

Congenital malformation of biliary tract

8.18

7.73

1.1

1.2

—

Recurrent dislocation and subluxation of joint

351

2.08

7.72

1.2

—

0.58

—

Dental caries 1, only avohilmo

949

3966

1.23

7.71

1.2

16.76

10.54

u/ml

0.19

Other and unspecified psoriasis

407

2.00

7.67

1.2

—

10.94

—

Other or ill-defined heart diseases

275

2.21

7.56

1.3

1.1

—

10.98

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

6.41

7.52

1.3

—

Transport accidents

521

3570

1.30

7.47

1.3

1.2

25.93

14.27

u/ml

—

Injuries to the head

1309

7232

1.18

7.44

1.2

7.06

15.17

u/ml

0.56

108

Other obstetric conditions, not elsewhere classified

431

2098

1.34

7.42

1.3

1.2

0.46

17.72

u/ml

—

Open wound of wrist and hand

455

3431

1.32

7.39

1.3

1.2

16.24

14.65

u/ml

—

Suppurative and unspecified otitis media

404

2677

1.34

7.37

1.2

1.68

19.32

u/ml

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

418

2032

1.34

7.24

1.3

1.2

0.44

18.13

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

196

1298

1.52

7.23

1.3

1.2

10.48

19.43

u/ml

—

Adult-onset Still disease

6.09

7.20

1.3

1.2

—

Exclusions for E4_PCOS_CONSORTIUM

945

4896

1.21

7.16

1.2

25.06

11.34

u/ml

0.42

Mucosal proctocolitis

147

914

1.62

7.15

1.2

—

5.22

—

Coxarthrosis, primary

601

4131

1.27

7.11

1.3

1.2

2.58

13.31

u/ml

—

Other chronic obstructive pulmonary disease

398

2479

1.34

7.10

1.2

7.60

6.24

u/ml

—

Disorders of continuity of bone

116

682

1.72

7.03

1.2

—

13.96

—

Hypertension, Pulmonary Arterial

4.15

7.00

1.3

1.2

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

332

2418

1.37

6.84

1.2

0.72

21.88

u/ml

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

384

2893

1.34

6.82

1.2

0.76

10.43

u/ml

—

Other/unspecified crystal arthropathies

4.98

6.81

1.4

1.3

—

Other diseases of the digestive system

291

2100

1.39

6.79

1.2

—

15.50

—

Glucagon-like peptide-1 (GLP-1) analogues

568

3695

1.27

6.79

1.1

1.2

8.23

12.82

u/ml

—

Haemophagocytic lymphohistiocytosis

17.73

6.75

1.3

1.4

—

Aortic valve malfunction, age under 60 years

104

602

1.75

6.68

1.3

1.2

3.30

9.10

u/ml

—

Retinal detachments and breaks

353

2638

1.35

6.63

1.2

19.42

15.72

u/ml

—

Eosinophilia

106

2.93

6.63

1.3

1.2

—

Congenital malformations, deformations and chromosomal abnormalities

689

5363

1.24

6.60

1.2

1.11

18.14

u/ml

—

Injuries to the shoulder and upper arm

903

6308

1.20

6.58

1.2

7.39

13.87

u/ml

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

6.64

6.55

1.3

—

GI-bleeding

288

2088

1.39

6.55

1.2

—

15.50

—

Adjustment and management of implanted device

163

1063

1.54

6.49

1.2

—

0.60

—

Coronary atherosclerosis

703

3678

1.24

6.47

1.3

1.2

8.27

12.09

u/ml

0.25

Left ventricular outflow tract obstruction (LVOTO), broad definition

110

653

1.70

6.46

1.3

1.2

3.30

9.10

u/ml

—

Benign neoplasm: Ascending colon

134

838

1.62

6.43

1.3

1.2

—

11.31

—

Myasthenia gravis

114

2.82

6.38

1.1

1.2

—

Obesity, other/unspecified

384

2924

1.32

6.36

1.2

6.19

16.47

u/ml

—

177

1116

1.51

6.33

1.2

9.67

0.55

u/ml

—

Primary_lymphoid and hematopoietic malignant neoplasms

238

1682

1.42

6.31

1.3

1.2

1.68

18.90

u/ml

—

Molar incisor enamel hypoplasia

158

2.47

6.29

1.1

1.2

—

Other otitis externa (chronic)

416

1.88

6.26

1.1

1.2

—

10.92

—

Special screening examination for other diseases and disorders

430

1.85

6.23

1.3

1.2

—

6.94

—

Use of donepezil

964

0.49

6.17

1.1

1.2

—

0.77

—

243

1530

1.41

6.16

1.3

1.2

8.36

4.02

u/ml

—

Other and unspecified localized connective tissue disorders

5.71

6.15

1.2

—

Benign neoplasm: Ascending colon

134

848

1.60

6.14

1.3

1.2

—

5.71

—

Otitis externa, unspecified

123

763

1.63

6.12

1.3

1.2

—

5.71

—

Other lack of coordination

2.98

5.96

1.2

—

Car occupant injured in other and unspecified transport accidents

205

1428

1.45

5.94

1.3

1.2

34.50

6.85

u/ml

—

Benign neoplasm of other and ill-defined parts of digestive system

196

1356

1.46

5.91

1.3

1.2

10.48

18.22

u/ml

—

Dysplasia of cervi uteri

296

1690

1.36

5.89

1.3

1.2

0.67

20.11

u/ml

—

Protozoal diseases

161

2.42

5.87

1.1

1.2

—

Medical abortion

843

3818

1.20

5.85

1.3

1.2

9.59

15.17

u/ml

0.26

Nummular dermatitis

484

1.78

5.84

1.2

—

7.04

—

Appendectomy

762

6107

1.21

5.81

1.3

1.2

12.43

16.88

u/ml

—

Sudden idiopathic hearing loss

107

651

1.66

5.78

1.4

1.2

—

9.23

—

Fracture of rib(s), sternum and thoracic spine

271

1990

1.37

5.77

1.2

10.92

13.23

u/ml

—

Diabetes, varying definitions

1229

6335

1.16

5.71

1.2

13.60

15.73

u/ml

0.12

Extrapyramidal and movement disorders

366

2813

1.31

5.71

1.3

1.2

16.17

12.94

u/ml

—

Personality disorders, excluding more controls

280

2072

1.36

5.69

1.2

0.92

19.89

u/ml

—

Colonic or urogenital fistula

289

2153

1.35

5.63

1.3

1.2

11.70

17.85

u/ml

—

Other or unspecified common variable immunodeficiency

5.23

5.63

1.3

—

Pneumocystosis

2.82

5.61

1.1

1.2

—

Female infertility

384

1823

1.31

5.60

1.2

0.40

21.83

u/ml

—

Diabetic nephropathy, excluding more controls

138

746

1.56

5.60

1.2

13.36

5.58

u/ml

—

Cholecystectomy

798

5919

1.20

5.54

1.2

11.91

12.21

u/ml

0.01

Achilles tendinitis

113

706

1.62

5.51

1.2

—

10.38

—

Diabetes mellitus

1232

6365

1.16

5.48

1.2

13.60

15.73

u/ml

0.12

Diabetic nephropathy

140

909

1.53

5.44

1.2

13.36

9.48

u/ml

—

Organic, including symptomatic, mental disorders

274

2644

0.74

5.38

1.1

1.2

0.53

8.73

u/ml

—

Disorders of refraction and accommodation

286

2138

1.34

5.33

1.3

1.2

23.82

19.87

u/ml

—

Angina pectoris

601

3316

1.23

5.32

1.2

26.81

13.89

u/ml

—

Abrasion of teeth

302

1673

1.33

5.26

1.3

1.2

3.73

11.61

u/ml

—

Anaemia in chronic diseases classified elsewhere

126

2.52

5.26

1.2

—

Unspecified threat to breathing

3.20

5.15

1.3

1.2

—

Hypoplasia of dental enamel , including avohilmo

150

2.35

5.14

1.1

1.3

—

Benign neoplasm: Rectum

170

1179

1.45

5.12

1.3

1.2

—

15.75

—

Other female pelvic inflammatory diseases

206

1480

1.40

5.11

1.2

—

15.60

—

Vitiligo

2.91

5.07

1.0

1.2

—

Cerebral palsy and other paralytic syndromes

117

753

1.57

5.06

1.3

1.2

—

6.31

—

Type 2 diabetes

1167

6014

1.15

5.06

1.2

11.98

14.20

u/ml

0.13

Bronchitis, not specified as acute or chronic

536

1.68

5.05

1.2

—

9.27

—

Degenerative macular diseases

116

747

1.57

5.01

1.2

11.18

0.51

u/ml

—

Eustachian salpingitis and obstruction

547

1.66

4.95

1.2

1.3

—

6.88

—

Injuries to unspecified part of trunk, limb or body region

100

624

1.62

4.95

1.2

—

7.04

—

Lumbosacral root disorders, not elsewhere classified

3.01

4.94

1.1

1.2

—

Other nonscarring hair loss

3.11

4.91

1.4

1.2

—

Misadventures to patients during surgical and medical care

149

1017

1.48

4.90

1.1

1.2

—

19.42

—

Benign neoplasm: Rectum, anus and anal canal

191

1365

1.41

4.89

1.3

1.2

—

14.83

—

Mucinosis of skin

10.36

4.88

1.2

1.3

—

Common variable immunodeficiency

3.76

4.86

1.3

1.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.44

4.84

1.4

1.3

—

Other and unspecified trigeminal disorders

2.81

4.83

1.2

—

Dislocation, sprain and strain of joints and ligaments of knee

683

5324

1.20

4.82

1.3

1.2

29.30

16.17

u/ml

0.32

Disorders resulting from impaired renal tubular function

203

2.11

4.79

1.2

—

Disorders of calcium metabolism

394

1.77

4.78

1.4

1.2

—

9.15

—

Maternal care for other conditions predominantly related to pregnancy

266

1984

1.33

4.78

1.2

1.3

—

17.00

—

Other chronic obstructive pulmonary disease, including avohilmo

500

3386

1.23

4.77

1.2

5.99

11.67

u/ml

—

Pustular psoriasis

322

1.86

4.76

1.3

1.2

—

10.84

—

Livedoid vasculitis

4.48

4.74

1.1

1.3

—

Other and unspecified primary disorders of muscles

3.36

4.70

1.8

1.2

—

Appendicitis, broad definition

845

6620

1.17

4.65

1.3

1.2

18.52

15.00

u/ml

0.11

Myocardial infarction, without ST-elevation

325

2334

1.29

4.64

1.2

10.83

10.30

u/ml

—

Other eating disorders

354

1.80

4.62

1.1

1.2

—

10.82

—

conjunctival degenerations and deposits

141

2.32

4.60

1.6

1.2

—

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1244

0.61

4.57

1.1

1.2

—

27.40

—

Other and unspecified nonscarring hair loss

3.42

4.55

1.5

1.2

—

Hepatomegaly and splenomegaly, not elsewhere classified

3.26

4.55

1.1

—

Diseases of appendix

850

6654

1.17

4.54

1.3

1.2

18.52

14.86

u/ml

0.12

Other sexually transmitted chlamydial diseases

423

1.72

4.53

1.2

1.3

—

7.81

—

Other symptoms and signs involving cognitive functions and awareness

415

3132

1.25

4.52

1.2

22.42

8.76

u/ml

—

Congenital deformities of hip

111

2.49

4.51

1.3

1.2

—

Primary coxarthrosis, bilateral

263

2003

1.32

4.51

1.2

4.22

16.70

u/ml

—

Social phobias

515

1.65

4.49

1.1

1.2

—

6.89

—

Disorders of breast

606

4705

1.20

4.43

1.2

8.46

14.12

u/ml

0.36

Calcific tendinitis of shoulder

360

1.77

4.38

1.2

—

57.30

—

Insulin, combination of fast acting with intermediate-acting or long-acting

602

4649

1.20

4.38

1.2

6.77

13.89

u/ml

0.46

Cerebrovascular diseases

747

4557

1.18

4.36

1.2

6.57

12.21

u/ml

—

Kela-code for severe mental illness

242

3171

0.76

4.32

1.2

44.46

18.80

u/ml

—

Coxarthrosis, primary, with hip surgery

435

3356

1.23

4.30

1.3

1.2

2.65

13.91

u/ml

—

Dialysis

226

1.98

4.28

1.2

1.1

—

Insulin, fast-acting

354

2819

1.26

4.26

1.2

9.73

19.43

u/ml

—

Benign neoplasm: Rectum, anus and anal canal

191

1400

1.37

4.26

1.3

1.2

—

22.99

—

Substance abuse, excluding more controls

553

4035

1.20

4.22

1.2

0.79

16.91

u/ml

—

Insulin medication

602

4325

1.19

4.22

1.2

6.77

12.58

u/ml

0.36

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

109

2.46

4.21

1.3

1.1

—

Infective bursitis

134

2.27

4.18

1.3

1.2

—

Other chondrocalcinosis

2.89

4.18

1.3

1.1

—

Type 2 diabetes, definitions combined

1096

5738

1.14

4.17

1.2

11.89

12.60

u/ml

0.04

Acute appendicitis

785

6376

1.16

4.14

1.3

1.2

18.52

15.30

u/ml

0.10

Renal tubulo-interstitial disorders in diseases classified elsewhere

2.96

4.13

1.5

1.1

—

Other dialysis

168

2.12

4.11

1.3

1.1

—

Benign neoplasm: Rectum

170

1231

1.39

4.11

1.3

1.2

—

27.51

—

Benign neoplasm: Caecum

647

1.54

4.10

1.2

—

7.01

—

Occupational exposure to risk-factors

189

2.04

4.07

1.2

1.1

—

Insulin, intermediate and long-acting

525

4300

1.20

4.03

1.2

7.63

13.87

u/ml

—

Injury of muscle and tendon at shoulder and upper arm level

340

2718

1.26

4.02

1.2

0.52

15.46

u/ml

—

Discitis, unspecified

2.65

4.01

1.2

1.1

—

COPD, hospital admissions

400

2751

1.23

3.98

1.2

7.60

12.71

u/ml

—

Aortic arch syndrome [Takayasu]

8.05

3.98

1.3

—

Lung diseases due to external agents

113

764

1.49

3.97

1.4

1.2

5.46

7.01

u/ml

—

Benign neoplasm: Caecum

655

1.53

3.89

1.2

—

7.90

—

Drug-induced Cushing's syndrome

13.70

3.89

1.0

1.4

—

Injury of unspecified body region

466

1.63

3.87

1.2

—

11.04

—

Intercostal neuropathy

3.18

3.87

1.2

—

Type 2 diabetes, strict (exclude DM1)

1095

5767

1.14

3.86

1.2

11.89

12.60

u/ml

0.04

Infarction of spleen

3.96

3.86

1.4

1.2

—

Insulin, fast-acting or short human

355

2864

1.24

3.86

1.2

9.73

18.46

u/ml

—

Monoplegia

2.48

3.85

1.2

—

Vertigo of central origin

2.53

3.84

1.1

1.2

—

Other condition

135

952

1.43

3.83

1.2

—

5.22

—

Other contact dermatitis

538

1.57

3.82

1.3

1.2

—

14.06

—

Dental caries 2 and operation codes, only avohilmo

852

4595

1.15

3.80

1.2

45.66

9.01

u/ml

1.32

Rapidly progressive nephritic syndrome

7.26

3.77

1.6

1.2

—

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

2.64

3.77

1.5

1.2

—

Heterophoria

564

1.56

3.77

1.2

—

9.17

—

Hypersplenism

4.22

3.76

1.2

1.4

—

Other demyelinating diseases of the central nervous system

274

1.82

3.74

1.3

1.2

—

10.80

—

Other disorders of peripheral nervous system

3.40

3.69

1.2

1.3

—

Nail dystrophy

3.39

3.68

1.2

—

Mature T/NK-cell lymphomas, hilmo

2.60

3.68

1.5

1.2

—

Ulcerative proctitis

403

1.66

3.67

1.3

1.2

—

9.08

—

Myocardial infarction

459

2734

1.21

3.67

1.2

13.37

12.56

u/ml

—

Acrodermatitis chronica atrophicans

7.06

3.66

1.5

1.2

—

COPD, early/later onset

399

2767

1.22

3.62

1.2

7.60

12.71

u/ml

—

Left bundle-branch block

420

1.63

3.62

1.3

1.2

—

7.94

—

Acute appendicitis, no complications

617

5268

1.17

3.60

1.3

1.2

16.54

17.96

u/ml

—

Congenital malformations of gallbladder, bile ducts and liver

2.79

3.55

1.1

1.2

—

Other and unspecified disorders of orbit

3.72

3.54

1.3

1.1

—

Other ulcerative colitis

386

1.65

3.48

1.2

—

10.92

—

Transient ischemic attack

487

3397

1.19

3.43

1.2

23.31

8.97

u/ml

0.43

Asthma mixed form (mode), excluding more controls

282

1.75

3.40

1.1

1.2

—

0.62

—

Familial chondrocalcinosis

9.92

3.39

1.7

1.1

—

Operations 2 for CAVS

221

1680

1.29

3.37

1.3

1.2

0.80

7.27

u/ml

—

Calcific aortic valvular stenosis, diagnosis (helper)

221

1680

1.29

3.37

1.3

1.2

0.80

7.27

u/ml

—

Asthma mixed form (mode)

283

1.75

3.36

1.1

1.2

—

0.62

—

Calcific aortic valvular stenosis, operated

221

1681

1.29

3.36

1.3

1.2

0.80

7.27

u/ml

—

Calcific aortic valvular stenosis

221

1681

1.29

3.36

1.3

1.2

0.80

7.27

u/ml

—

Peritonsillar abscess

203

1562

1.31

3.34

1.1

1.2

6.92

25.27

u/ml

—

Parapsoriasis

115

2.22

3.32

1.0

1.2

—

Calcific aortic valvular stenosis, including rheumatic fever

222

1691

1.29

3.32

1.3

1.2

0.80

6.95

u/ml

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

495

0.48

3.31

1.1

1.2

—

0.56

—

Other and unspecified acquired haemolytic anaemias

2.87

3.30

1.3

1.2

—

Other viral hepatitis

384

1.63

3.30

1.2

—

9.07

—

Pemphigoid

142

2.08

3.29

1.1

1.2

—

COPD related to multimorbidity

327

2241

1.23

3.29

1.2

7.60

17.34

u/ml

—

Viral hepatitis

471

1.56

3.28

1.2

—

7.83

—

Speech disturbances, not elsewhere classified

519

1.53

3.27

1.2

—

10.98

—

Erectile dysfunction, exclusion

5.60

3.24

1.1

1.5

—

Other and unspecified nail disorders

130

2.12

3.22

1.2

—

Other acquired deformities of ankle and foot

3.04

3.17

1.2

—

Other papulosquamous disorders

2.69

3.17

1.1

1.2

—

Hypoplasia of dental enamel, prenatal , including avohilmo

4.70

3.16

1.1

1.2

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

681

4839

1.15

3.15

1.3

1.2

0.48

16.86

u/ml

3.41

Type 2 diabetes, definitions combined, including avohilmo

1090

5771

1.12

3.15

1.2

13.68

12.75

u/ml

0.05

Statin medication

845

4172

1.14

3.14

1.2

29.73

8.94

u/ml

0.68

Unspecified mental disorder

293

3596

0.81

3.14

1.2

37.12

17.04

u/ml

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

143

1059

1.36

3.11

1.2

—

4.47

—

Burns and corrosions

128

932

1.38

3.10

1.2

—

5.71

—

Felty syndrome

3.58

3.09

1.3

1.2

—

Other diseases of pancreas

464

1.54

3.04

1.2

—

10.82

—

Parodontitis or/and operation codes

760

3965

1.14

3.03

1.2

7.55

17.96

u/ml

—

Nontoxic goitre/thyroid nodule

322

2653

1.22

3.00

1.2

3.70

11.06

u/ml

—

Postpartum haemorrhage due to anatomy

117

845

1.39

3.00

1.3

—

22.15

—

Postzoster neuralgia

2.51

2.99

1.2

1.1

—

Adenocarcinoma and ductal carcinoma of pancreas

176

0.28

2.98

1.0

1.1

—

Schizoaffective disorder

553

0.54

2.97

1.2

—

7.90

—

Chronic pancreatitis

105

746

1.42

2.96

1.2

—

29.18

—

Vasomotor rhinitis (mode)

524

1.50

2.95

1.3

1.2

—

10.90

—

Acquired coagulation factor deficiency

7.28

2.94

1.0

1.1

—

Injuries to the hip and thigh

419

3239

1.19

2.94

1.2

0.54

13.17

u/ml

—

Pigmented purpuric dermatosis

2.66

2.91

1.1

1.2

—

Myeloproliferative diseases

526

1.50

2.90

1.1

1.2

—

9.22

—

COPD, hospital admission 2, with asthma infections

257

1767

1.24

2.89

1.2

4.38

12.55

u/ml

—

Nonspecific lymphadenitis

446

1.54

2.89

1.3

1.2

—

6.94

—

Benign neoplasm: Other and unspecified parts of small intestine

109

2.16

2.88

1.2

—

Mouth breathing

397

3346

1.19

2.87

1.2

41.34

14.84

u/ml

—

Glaucoma

523

3955

1.16

2.87

1.2

7.56

11.98

u/ml

—

Other and unspecified cicatricial alopecia

4.25

2.87

1.3

1.2

—

Haemolytic-uraemic syndrome

4.77

2.87

1.3

1.2

—

Malignant neoplasm of bronchus and lung

974

0.67

2.86

1.1

1.2

—

11.50

—

Major coronary heart disease event excluding revascularizations

604

3624

1.15

2.84

1.2

22.94

10.63

u/ml

0.39

Synovial hypertrophy, not elsewhere classified

2.83

2.84

2.2

1.2

—

Fall on same level involving ice and snow

583

5073

1.15

2.84

1.2

7.79

13.33

u/ml

0.39

Other and unspecified pemphigoid

2.73

2.84

1.1

1.2

—

Gout due to impairment of renal function

2.71

2.83

1.1

1.2

—

Substance abuse

553

4582

1.16

2.81

1.2

0.79

15.58

u/ml

—

Duodenal ulcer

579

1.46

2.80

1.1

1.2

—

7.87

—

Ovarian dysfunction, other/unspecified

2.97

2.80

1.3

1.2

—

Bipolar affective disorders

193

1516

1.28

2.79

1.2

32.02

19.77

u/ml

—

Diabetes medication

1180

6493

1.11

2.78

1.2

12.31

15.73

u/ml

0.23

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

1075

5918

1.11

2.76

1.2

15.27

12.54

u/ml

0.16

Personality disorders

280

2296

1.22

2.76

1.2

0.92

22.14

u/ml

—

Other prurigo

2.42

2.76

1.4

1.1

—

Marginal zone B-cell lymphoma

2.58

2.75

1.3

1.2

—

Other superficial injuries of ankle and foot

3.07

2.73

1.5

1.2

—

Other and unspecified diseases of blood and blood-forming organs

146

1.95

2.73

1.4

1.2

—

Superficial injury of hip and thigh

122

902

1.36

2.72

1.1

1.2

—

6.30

—

Fracture of lower leg, including ankle

547

4741

1.15

2.68

1.2

8.42

13.19

u/ml

—

Pyoderma gangrenosum

2.74

2.66

1.4

1.2

—

Sequelae of injuries of upper limb

669

1.41

2.66

1.2

—

9.15

—

Other disorders of kidney and ureter

110

804

1.38

2.66

1.1

1.2

—

6.99

—

Magnesium deficiency

4.26

2.63

1.3

1.2

—

2.18

2.62

1.3

1.2

—

Cryoglobulinemia

7.69

2.60

1.6

1.4

—

Other specific arthropathies

5.84

2.60

1.2

1.3

—

Cystic fibrosis

5.77

2.59

1.8

1.2

—

Disorders of parathyroid gland, other and/or unspecified

2.82

2.58

1.5

1.2

—

Papilloedema, unspecified

135

1.96

2.58

1.2

—

Carcinoma in situ of vulva

2.58

2.57

1.1

1.2

—

Infection of intervertebral disc (pyogenic)

2.55

1.1

1.2

—

Benign neoplasm: Other and unspecified parts of small intestine

115

2.04

2.54

1.2

—

Psoas tendinitis

3.61

2.52

1.4

1.2

—

Desensitization to allergens

356

1.56

2.52

1.2

—

10.82

—

Mental and behavioural disorders due to psychoactive substance use

567

4689

1.14

2.52

1.2

0.79

17.26

u/ml

—

Recurrent dislocation of patella

262

1.65

2.51

1.1

1.2

—

0.58

—

Injury of muscle and tendon at hip and thigh level

652

1.41

2.51

1.2

—

7.04

—

Congenital malformations of trachea and bronchus

2.45

2.50

1.3

1.1

—

Blindness, monocular

2.89

2.50

1.0

1.3

—

Infection due to other mycobacteria

2.23

2.50

1.3

1.2

—

All dysplastic lesions of the cervix uteri, vagina or vulva

336

2817

1.19

2.49

1.3

1.2

0.65

18.40

u/ml

—

Cardiomyopathies, Primary/intrinsic

686

1.39

2.49

1.1

1.2

—

19.66

—

Toxic erythema

5.36

2.46

1.0

1.4

—

Chronic mastoiditis

152

1.87

2.44

1.2

1.1

—

Acne varioliformis

5.27

2.44

1.2

1.3

—

Other and unspecified myoneural disorders

3.50

2.44

1.1

1.3

—

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

6.89

2.44

1.2

1.4

—

Lichen planopilaris

3.85

2.42

1.4

1.3

—

Henoch-Schönlein purpura nephritis (HSPN)

3.80

2.40

1.4

1.2

—

Sequelae of injuries of neck and trunk

175

1.79

2.40

1.3

1.2

—

Atlantoaxial subluxation

2.69

2.40

1.3

1.2

—

Allergic bronchopulmonary aspergillosis (ABPA)

6.44

2.39

1.4

1.3

—

Systemic disorders of connective tissue in diseases classified elsewhere

4.27

2.39

1.1

1.2

—

Ventral hernia

220

1791

1.23

2.39

1.1

1.2

—

19.81

—

Alcohol abuse counselling and surveillance

104

2.05

2.39

1.1

1.2

—

Other arterial embolism and thrombosis

139

1.89

2.38

1.2

1.1

—

Viral encephalitis, not elsewhere classified/unspecified

118

1.98

2.37

1.1

1.2

—

Major coronary heart disease event

665

3938

1.13

2.35

1.2

8.74

15.60

u/ml

0.42

Other and unspecified atrophic disorders of skin

3.35

2.35

1.4

1.2

—

Other nonautoimmune haemolytic anaemias

5.02

2.33

1.0

1.3

—

Other CVD

142

1101

1.29

2.33

1.2

0.76

4.98

u/ml

—

Acute nephritic syndrome

119

1.96

2.32

1.4

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

1114

6217

1.10

2.32

1.2

15.27

12.02

u/ml

0.19

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

154

0.32

2.29

1.0

1.1

—

Androgenic alopecia

2.34

2.28

1.1

1.2

—

Need for immunization against other single viral diseases

120

1.95

2.28

1.0

1.2

—

Other congenital malformations of the digestive system

268

1.61

2.28

1.2

—

Nonalcoholic steatohepatitis

2.41

2.26

1.1

1.2

—

Hypoplasia of dental enamel, prenatal

5.91

2.25

1.2

1.1

—

Other and unspecified aplastic anaemias

2.38

2.24

1.1

1.2

—

Ulcerative rectosigmoiditis

565

1.41

2.24

1.2

—

6.23

—

Infectious mononucleosis

565

1.41

2.23

1.3

1.2

—

7.83

—

Puerperal sepsis

154

1217

1.27

2.22

1.2

—

13.37

—

Pre-eclampsia or poor fetal growth

358

3064

1.17

2.21

1.3

1.2

29.90

12.63

u/ml

—

Other acantholytic disorders

3.92

2.20

1.1

1.2

—

Abnormal findings in nipple discharge synovial fluid wound secretions

108

1.98

2.18

1.1

1.2

—

Short stature, not elsewhere classified

114

1.91

2.17

1.4

1.3

—

Disorders of porphyrin and bilirubin metabolism

2.15

1.3

1.2

—

Other specified and unspecified disorders of iris and ciliary body

3.33

2.13

1.3

1.2

—

Transient acantholytic dermatosis [Grover]

5.36

2.11

1.2

—

Injuries to the elbow and forearm

724

5891

1.11

2.11

1.3

1.2

20.17

11.93

u/ml

0.39

Intermittent hydrarthrosis

5.23

2.10

1.0

1.5

—

Acute bronchiolitis

312

1.51

2.09

1.2

—

Embedded and impacted teeth

243

1721

1.20

2.09

1.3

1.2

36.06

11.91

u/ml

—

Kela-code for behavioural disturbances in mental retardation

0.00

2.07

0.0

1.1

—

Biliary cirrhosis, NAS

4.19

2.07

1.7

1.2

—

Ectropion of eyelid

161

1.75

2.06

1.5

1.1

—

Pregnancy with abortive outcome

812

3838

1.11

2.06

1.2

17.81

15.17

u/ml

0.09

Acute inflammation of orbit

2.57

2.04

1.4

1.2

—

Burns and corrosions of external body surface, specified by site

704

1.34

2.03

1.3

1.2

—

6.31

—

Adenocarcinoma of pancreas

144

0.34

2.03

1.0

1.2

—

Failure in dosage during surgical and medical care

4.97

1.99

1.2

—

Localized skin eruption due to drugs and medicaments

2.12

1.99

1.3

1.2

—

Acute myeloid leukaemia and myelodysplastic syndromes

2.11

1.98

1.1

1.2

—

Contraceptive management

449

2771

1.14

1.98

1.3

1.2

17.09

14.78

u/ml

—

Alkalosis

3.96

1.97

1.0

1.3

—

Benign neoplasm: Ribs, sternum and clavicle

3.96

1.97

1.7

1.3

—

Chronic viral hepatitis

313

1.51

1.96

1.1

1.2

—

10.82

—

Syndrome of inappropriate secretion of antidiuretic hormone

3.05

1.96

1.3

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

556

4339

1.12

1.95

1.3

1.2

13.49

14.90

u/ml

0.04

Other and unspecified bullous disorders

2.16

1.95

1.1

1.2

—

Necrobiosis lipoidica, not elsewhere classified

2.64

1.95

1.5

1.3

—

Other bursitis, not elsewhere classified

2.49

1.95

1.1

1.2

—

Seborrhoeic keratosis

184

1508

1.22

1.94

1.3

1.2

0.38

10.43

u/ml

—

Myelodysplastic syndrome

2.62

1.94

1.1

1.2

—

Leiomyoma of uterus

764

3935

1.11

1.92

1.2

23.33

9.73

u/ml

—

Ectopic pregnancy

201

1666

1.21

1.91

1.2

1.3

—

13.68

—

Aspergillosis

2.37

1.90

1.2

—

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

212

1.62

1.90

1.2

—

10.00

—

Vitamin A deficiency

2.74

1.89

1.2

1.3

—

Anomalies of dental arch relationship, including avohilmo

191

1414

1.22

1.89

1.3

1.2

11.26

19.41

u/ml

—

Other and unspecified diseases of spleen

2.96

1.89

1.3

—

Viral pneumonia (known virus, not influenza)

136

1.79

1.89

1.1

1.2

—

Use of biperiden

331

0.54

1.88

1.2

—

10.84

—

Ankylosing hyperostosis [Forestier]

2.12

1.88

1.1

1.2

—

Other and unspecified papulosquamous disorders

2.93

1.88

1.1

1.3

—

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

0.00

1.88

0.0

1.2

—

Congenital lactase deficiency

3.70

1.87

1.0

1.3

—

Disorders in reading

2.05

1.87

1.3

1.2

—

Chronic suppurative otitis media, including avohilmo

500

1.39

1.86

1.2

—

9.27

—

Vulvovaginal ulceration/inflammation in other diseases

450

1.41

1.86

1.2

—

6.23

—

Cardiomyopathy (excluding other)

724

1.32

1.85

1.1

1.2

—

19.66

—

Disease of hard tissues of teeth, NOS

2.16

1.84

1.1

1.2

—

Eclampsia

3.20

1.84

1.1

1.3

—

Acidosis

108

1.88

1.83

1.2

—

Effects of air pressure and water pressure

2.65

1.83

1.2

—

Neuroendocrine tumor and carcinoma of stomach

2.85

1.82

1.0

1.3

—

Dislocation, sprain and strain of joint and ligaments of hip

207

1.61

1.81

1.1

—

Wet age-related macular degeneration

116

894

1.28

1.81

1.4

1.2

9.57

0.60

u/ml

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

585

4132

1.11

1.80

1.3

0.48

17.47

u/ml

3.17

Other disorders of electrolyte and fluid balance, not elsewhere classified

2.39

1.79

1.0

1.2

—

Drug-induced interstitial lung disorders, unspecified

4.09

1.75

1.0

1.2

—

Actinomycosis

3.02

1.75

1.0

1.1

—

Thromboangiitis obliterans

3.02

1.74

1.3

—

Acquired clawhand, clubhand, clawfoot and clubfoot

2.99

1.74

1.4

1.3

—

Precocious puberty

2.99

1.74

1.1

1.2

—

Melanoma in situ of other and unspecified parts of face

2.17

1.73

1.2

—

Ductal carcinoma of pancreas

0.00

1.73

0.0

1.3

—

Arthropathy in Crohn disease

2.10

1.72

1.1

1.2

—

Acquired absence of limb

2.34

1.72

1.2

1.3

—

Spontaneous abortion

551

3366

1.12

1.71

1.3

15.22

17.31

u/ml

0.08

Other and unspecified hypertrophic disorders of skin

2.44

1.70

1.2

—

Macular pucker

120

956

1.26

1.69

1.3

1.2

7.22

6.78

u/ml

—

Benign neoplasm: Eye, unspecified

2.67

1.68

1.4

1.3

—

Neuroendocrine tumor and carcinoma of stomach, excluding all cancers (controls excluding all cancers)

2.66

1.68

1.0

1.3

—

Carcinoma in situ of skin of scalp and neck

1.88

1.67

1.1

1.2

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

112

1.81

1.66

1.3

1.2

—

Pneumoconiosis due to asbestos and other mineral fibres

1.99

1.65

1.0

1.1

—

Other porphyria

3.79

1.65

1.0

1.2

—

Follow-up examination after treatment for malignant neoplasms

512

1.35

1.64

1.3

1.2

—

19.53

—

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

131

0.38

1.64

1.0

1.2

—

Disorders of adult personality and behaviour

280

2424

1.16

1.64

1.2

0.92

22.14

u/ml

—

Maternal care for other known or suspected fetal problems

274

1513

1.17

1.63

1.3

20.43

11.39

u/ml

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

548

1.34

1.62

1.2

—

9.17

—

Alzheimer’s disease (Early onset)

211

0.47

1.62

1.1

1.2

—

Benign neoplasm: Tonsil

1.94

1.62

1.2

—

Drug-induced thyroiditis

3.16

1.61

1.3

1.1

—

Calcaneal spur

2.03

1.61

1.1

1.2

—

Type 1 diabetes

229

1957

1.17

1.57

1.2

11.30

22.15

u/ml

—

Stroke, including SAH

572

3832

1.11

1.57

1.2

8.94

10.67

u/ml

—

Volume depletion

491

1.35

1.56

1.3

1.2

—

0.70

—

Other (not insulin) diabetes medications

1058

5925

1.08

1.56

1.2

11.13

12.60

u/ml

0.09

Benign neoplasm: Eye, unspecified

2.50

1.56

1.4

1.2

—

Whooping cough

2.33

1.55

1.0

1.3

—

Melanoma in situ of scalp and neck

3.49

1.55

1.0

1.2

—

Melanoma in situ of scalp and neck

3.49

1.55

1.0

1.2

—

Osteomyelitis of vertebra

3.43

1.54

1.8

1.1

—

Benign neoplasm: Ribs, sternum and clavicle

3.00

1.53

1.7

1.3

—

Diseases of peritoneum

685

1.29

1.53

1.1

1.2

—

7.04

—

Malignant neoplasm of retroperitoneum and peritoneum

0.00

1.53

0.0

1.2

—

Muscle wasting and atrophy, not elsewhere classified

2.64

1.53

1.0

1.3

—

Disorders of male genital organs in diseases classified elsewhere

2.64

1.52

1.6

1.1

—

Mixed disorders of conduct and emotions, excluding more controls

1.84

1.52

1.0

1.3

—

Wide developmental disorders, excluding more controls

129

1.70

1.52

1.2

1.3

—

Malignant neoplasm of gallbladder, excluding all cancers (controls excluding all cancers)

0.00

1.51

0.0

1.1

—

Burn and corrosion of hip and lower limb, except ankle and foot

131

1.70

1.50

1.4

1.2

—

Carcinoma in situ of breast

2.30

1.49

1.0

1.2

—

Other and unspecified disorders of pigmentation

2.27

1.48

1.4

1.2

—

Carcinoma in situ of oral cavity, oesophagus and stomach

2.56

1.46

1.0

1.2

—

Motor neuron disease

1.89

1.45

1.5

1.1

—

Benign neoplasm: Heart

2.82

1.45

2.7

1.3

—

Nonpyogenic thrombosis of intracranial venous system

2.07

1.45

1.2

—

Generalized pustular psoriasis

2.81

1.45

1.2

—

Shock, not elsewhere classified

2.34

1.44

1.2

—

Contact with other hot fluids

172

1.58

1.44

1.3

1.2

—

Carcinoma in situ of breast

2.25

1.43

1.0

1.2

—

Myocardial infarction, strict

393

2560

1.12

1.42

1.2

7.29

10.86

u/ml

—

Benign neoplasm of breast

124

1015

1.23

1.42

1.2

3.70

19.43

u/ml

—

Pre-eclampsia or eclampsia

246

2138

1.15

1.42

1.3

1.2

29.63

8.62

u/ml

—

Anorexia (incl.atypical)

422

1.36

1.42

1.2

—

10.82

—

Heart failure and coronary heart disease

235

1513

1.16

1.41

1.2

8.40

9.10

u/ml

—

Superficial injury of abdomen, lower back and pelvis

128

1052

1.22

1.41

1.2

—

4.82

—

Dementia in other diseases classified elsewhere

251

0.55

1.41

1.0

1.2

—

Mild or no visual impairment, binocular

2.47

1.41

1.3

1.2

—

Dacryoadenitis

2.12

1.40

1.0

1.1

—

Family history of malignant neoplasm

873

0.76

1.40

1.2

—

19.39

—

Benign neoplasm: Scapula and long bones of upper limb

2.03

1.39

1.2

—

Benign neoplasm: Other/unspecified site

104

1.75

1.38

1.4

1.1

—

Lesion of medial popliteal nerve

2.68

1.38

1.2

1.3

—

Disorder of the sleep-wake schedule

104

1.75

1.38

1.7

1.2

—

Cerebral arteritis

3.04

1.37

1.2

1.3

—

Hereditary spherocytosis

3.04

1.37

1.0

1.2

—

Migraine without aura, drug-induced

1.86

1.37

1.1

1.2

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

1.86

1.37

1.2

—

Use of rasagiline

162

0.49

1.37

1.1

1.2

—

Motor neuron disease (with DMD)

1.85

1.36

1.5

1.1

—

Intentional self-harm by jumping from a high place

0.00

1.36

0.0

1.2

—

Disorders of brain, other and unspecified

2.00

1.34

1.2

—

Distal bite

231

1.47

1.33

1.3

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

325

1.39

1.32

1.2

—

10.92

—

Glaucoma secondary to drugs

2.58

1.32

1.0

1.3

—

Other retinal artery occlusion

121

1.67

1.31

1.1

1.2

—

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

103

1264

0.81

1.31

1.2

—

14.86

—

Other abnormal findings in urine

1.86

1.31

1.2

—

Benign neoplasm: Tonsil

1.79

1.31

1.2

—

Melanoma in situ of other and unspecified parts of face

1.92

1.30

1.2

—

Lordosis

2.87

1.30

1.0

1.1

—

Toxic effect of other noxious substances eaten as food

2.84

1.29

1.0

1.1

—

Benign neoplasm: Scapula and long bones of upper limb

1.97

1.29

1.2

—

Glaucoma secondary to eye inflammation

2.04

1.29

1.1

1.3

—

Convergent concomitant strabismus

387

1.35

1.28

1.2

—

10.78

—

Other bursal cyst

1.81

1.28

1.3

1.2

—

Complications of the puerperium, not elsewhere classified

319

1.39

1.28

1.2

—

9.08

—

Other disorders of thyroid

1.77

1.26

1.3

1.2

—

Benign neoplasm: Floor of mouth

2.47

1.26

1.3

1.2

—

Lung transplant status

1.95

1.25

1.4

1.2

—

Benign leiomyoma with endometriosis

167

1427

1.17

1.24

1.2

—

16.26

—

Pemphigus

2.09

1.24

1.1

1.3

—

Benign neoplasm: Other/unspecified site

108

1.69

1.23

1.4

1.1

—

Erythema in diseases classified elsewhere

2.74

1.23

1.0

1.2

—

Contracture of joint

2.06

1.22

1.2

1.1

—

Labour and delivery complicated by umbilical cord complications

434

1.32

1.22

1.3

—

6.96

—

Type 1 diabetes, wide definition, subgroup 1

187

1612

1.16

1.22

1.3

1.2

11.30

29.29

u/ml

—

Disorders of puberty, other/unspecified

2.69

1.22

1.8

1.2

—

Overexertion and strenuous or repetitive movements

683

1.25

1.20

1.3

1.2

—

7.04

—

Lung transplantation

1.92

1.20

1.4

1.2

—

Portal vein thrombosis

1.77

1.20

1.2

—

Injury of nerves at hip and thigh level

2.37

1.20

1.2

—

Otorrhagia

2.15

1.19

1.1

1.2

—

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

122

1216

0.83

1.19

1.2

—

8.89

—

Congenital malformations of the respiratory system

117

1.64

1.19

1.3

1.1

—

Embolic stroke with flimmer

109

1.66

1.19

1.2

1.1

—

Malignant immunoproliferative diseases

1.96

1.18

1.3

1.2

—

Other conjunctival vascular disorders and cysts

149

1.56

1.18

1.1

1.2

—

Infliximab

2.04

1.18

1.2

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

0.00

1.17

0.0

1.2

—

Bullous pemphigoid

102

1.68

1.17

1.2

—

All dysplastic lesions of the cervix uteri

277

2460

1.13

1.17

1.3

1.2

0.65

18.26

u/ml

—

Congenital malformations of cardiac chambers and connections

0.00

1.17

0.0

1.1

—

Malignant neoplasm of other and ill-defined digestive organs

0.00

1.17

0.0

1.2

—

Changes in corneal membranes

2.59

1.16

1.4

1.3

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

1.75

1.16

1.5

1.2

—

Benign neoplasm: Orbit, unspecified

2.09

1.16

1.3

—

Secondary sideroblastic anaemia

2.57

1.16

1.0

1.3

—

Narcolepsy and cataplexy

2.08

1.16

1.3

1.2

—

Lack of expected normal physiological development

1.71

1.15

1.3

1.2

—

Cardiomyopathies, Secondary/extrinsic

0.00

1.15

0.0

1.3

—

Senility

2.51

1.15

1.0

1.1

—

Supervision of normal pregnancy

206

1349

0.87

1.15

1.2

1.3

—

17.65

—

IBD (strict) with PSC

1.88

1.14

1.3

1.2

—

Acute alcohol intoxication ICD-9

197

0.55

1.14

1.0

1.1

—

Preterm labour and delivery

289

2583

1.12

1.14

1.3

1.2

29.60

7.63

u/ml

—

Benign neoplasm: Hypopharynx

2.39

1.14

1.1

1.3

—

Benign leiomyoma with endometriosis

167

1440

1.16

1.13

1.2

—

17.84

—

Unspecified contracted kidney

2.04

1.13

1.1

1.2

—

Carcinoma in situ of skin of ear and external auricular canal

1.98

1.12

1.2

1.1

—

Benign neoplasm: Hypopharynx

2.31

1.12

1.1

1.2

—

Carcinoma in situ of oral cavity, oesophagus and stomach

2.31

1.11

1.0

1.1

—

Disorders of iron metabolism

1.69

1.11

1.1

1.2

—

Pre-eclampsia

223

1967

1.14

1.10

1.3

1.2

35.50

9.76

u/ml

—

Lagophthalmos

1.84

1.10

1.4

1.2

—

Tracheo-bronchomalasia

2.42

1.10

1.0

1.2

—

Disorders of speech understanding and production

222

1.42

1.09

1.1

1.2

—

Fracture of forearm

541

4678

1.08

1.09

1.3

1.2

25.32

13.02

u/ml

0.50

Disorders of pituitary gland, other and/or unspecified

2.23

1.09

1.1

1.3

—

Benign neoplasm of other and unspecified sites

210

1.44

1.09

1.4

1.1

—

Gangrene, not elsewhere classified

2.22

1.09

1.0

1.1

—

Spinal enthesopathy

112

1.61

1.08

1.2

1.1

—

Other and unspecified injuries of forearm

1.96

1.07

1.1

1.3

—

Recurrent and persistent haematuria

1.96

1.07

1.0

1.3

—

Personal history of medical treatment

1.95

1.07

1.5

1.3

—

Other and unspecified neuropathies

2.17

1.07

1.1

1.2

—

Benign neoplasm of other and unspecified sites

211

1.43

1.07

1.4

1.1

—

Inguinal hernia

505

3134

1.09

1.06

1.2

15.82

16.19

u/ml

0.01

Valvular operations

803

1.21

1.06

1.2

3.24

17.74

u/ml

—

Chronic inflammatory disorders of orbit

2.34

1.04

1.2

1.1

—

Food allergy

2.33

1.04

1.2

1.4

—

Autism spe, excluding more controls

1.68

1.04

1.2

1.3

—

Other specified and unspecified disorders of choroid

2.32

1.04

1.6

1.2

—

Thyrotoxicosis with toxic single thyroid nodule

1.86

1.04

1.2

—

Adrenogenital disorders

2.31

1.04

1.8

1.2

—

Benign neoplasm of other and unspecified intrathoracic organs

1.76

1.04

2.1

1.2

—

Deformity of finger(s)

2.09

1.04

1.3

1.2

—

Amyloidosis

122

1.57

1.03

1.1

1.2

—

Cervical root disorders

1.95

1.03

1.2

—

Intestinal adhesions without obstruction

518

1.26

1.02

1.1

1.2

—

18.63

—

Other factor of the environment

1.71

1.02

1.1

1.2

—

Tic and related disorders

1.90

1.02

1.1

1.3

—

Onycholysis

1.91

1.01

1.3

1.2

—

Qualitative platelet defects

2.05

1.01

1.1

1.2

—

Colitis, primary sclerosing

1.67

1.01

1.2

—

Acute thyroiditis

2.05

1.01

1.3

1.2

—

Other nutritional anaemias

1.89

1.01

1.0

1.3

—

Inflammatory disorders of male genital organs, not elsewhere classified

1.89

1.01

1.2

1.1

—

Epidural haemorrhage

2.02

1.00

1.3

1.2

—

Single delivery by caesarean section

166

1102

0.87

0.99

1.2

1.3

—

10.43

—

Benign neoplasm: Other and unspecified parts of mouth

223

1.40

0.99

1.1

—

Congenital malformations of ear causing impairment of hearing

0.00

0.99

0.0

1.2

—

104

1.60

0.99

1.2

—

Benign neoplasm of brain and other parts of central nervous system

441

1.28

0.98

1.3

1.2

—

10.86

—

Fetus and newborn affected by maternal complications of pregnancy

2.20

0.98

1.0

1.1

—

Mucinous and mucinous cystic tumor of rectum

0.00

0.98

0.0

1.2

—

Chondrosarcoma, excluding all cancers (controls excluding all cancers)

0.00

0.98

0.0

1.2

—

Injury of blood vessels at lower leg level

1.99

0.98

1.0

1.3

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

594

0.77

0.98

1.2

—

9.22

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.88

0.98

1.3

1.2

—

Alzheimer’s disease (undefined), excluding more controls

0.00

0.98

0.0

1.0

—

Epiphora

132

1.53

0.98

1.2

1.1

—

Contact with other specified venomous animals

1.83

0.98

1.1

1.2

—

Hypertrophy of (infrapatellar) fat pad

1.87

0.97

1.0

1.2

—

Exfoliative dermatitis

1.87

0.97

1.3

1.2

—

Colitis due to radiation

1.82

0.97

1.0

1.2

—

Carcinoma in situ of skin of scalp and neck

116

1.57

0.97

1.1

—

Colorectal adenocarcinoma

103

1219

0.84

0.97

1.2

—

18.11

—

Other congenital malformations of male genital organs

0.00

0.97

0.0

1.1

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

604

0.78

0.97

1.1

1.2

—

10.86

—

Unattended death

0.00

0.95

0.0

1.3

—

Open wound of abdomen, lower back and pelvis

174

1.45

0.95

1.3

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

346

1.31

0.95

1.2

—

10.92

—

Malignant immunoproliferative diseases

1.80

0.95

1.3

1.1

—

Unspecified human immunodeficiency virus [HIV] disease

1.80

0.95

1.0

1.2

—

Paraplegia, diplegia of upper limbs

133

1.52

0.95

1.2

—

Deaf mutism, not elsewhere classified

1.93

0.95

1.6

1.2

—

Heart failure and hypertrophic cardiomyopathy

1.66

0.95

1.0

1.2

—

Postinfectious hypothyroidism

1.92

0.95

1.0

1.3

—

Unstable angina pectoris

297

2229

1.11

0.95

1.2

34.39

11.38

u/ml

—

Disorder of thyroid, unspecified

1.63

0.95

1.3

—

Type 1 diabetes, wide definition

193

1706

1.13

0.94

1.3

1.2

11.30

26.46

u/ml

—

Benign neoplasm of breast

124

1064

1.17

0.94

1.2

3.70

20.76

u/ml

—

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

117

0.51

0.94

1.2

—

Malignant neoplasm of testis

1.73

0.93

1.2

1.1

—

Ascites

427

1.27

0.93

1.2

—

7.94

—

Benign neoplasm: Floor of mouth

2.20

0.93

1.3

1.1

—

Benign neoplasm of other and unspecified intrathoracic organs

1.69

0.92

2.1

1.2

—

Other osteochondropathies

499

1.25

0.92

1.3

1.2

—

9.15

—

Injury of urinary and pelvic organs

110

1.56

0.91

1.1

—

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

709

0.80

0.91

1.2

—

0.69

—

Benign neoplasm: Heart

2.12

0.90

2.7

1.2

—

Pure hyperglyceridaemia

135

1.49

0.89

1.2

—

Pityriasis rosea

1.93

0.89

1.0

1.3

—

Unspecified parasitic disease

1.81

0.89

1.3

—

Benign neoplasm of major salivary glands

656

1.21

0.88

1.3

1.2

—

14.01

—

Emotional disorders and disorders of social functioning with onset specific to childhood

302

1.31

0.88

1.1

1.3

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

1.81

0.88

1.1

1.2

—

Pregnancy hypertension

480

4020

1.08

0.88

1.3

1.2

15.65

13.92

u/ml

0.04

Carcinoma in situ of skin of lower limb, including hip

111

1.55

0.88

1.1

1.2

—

Pityriasis lichenoides chronica

2.04

0.88

1.0

1.2

—

Benign neoplasm of major salivary glands

657

1.21

0.87

1.3

1.2

—

7.01

—

Benign neoplasm: Orbit, unspecified

1.85

0.87

1.3

1.2

—

Intentional self-harm by unspecified means

1.68

0.86

1.2

—

Redundant prepuce, phimosis and paraphimosis

123

1060

1.16

0.85

1.2

—

30.93

—

Other congenital malformations of brain

1.97

0.85

1.5

1.3

—

Injury of nerves and spinal cord at thorax level

1.97

0.85

1.0

1.2

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

1.57

0.85

1.4

1.2

—

Ulcerative colitis (strict) with PSC

1.78

0.84

1.1

1.3

—

Reiter disease

1.77

0.83

1.5

1.3

—

Circumscribed brain atrophy

114

0.52

0.83

1.0

1.2

—

Small cell lung cancer

115

0.52

0.83

1.2

—

Small cell lung cancer, helper endpoint

115

0.52

0.83

1.2

—

Corneal scars and opacities

163

1.42

0.82

1.3

1.2

—

Other and unspecified disorders of binocular movement

1.90

0.82

1.0

1.3

—

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

1.65

0.82

1.2

1.1

—

Respiratory and cardiovascular disorders specific to the perinatal period

108

1.50

0.82

1.2

—

Other noninflammatory disorders of cervix uteri

355

1.27

0.82

1.2

—

33.79

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

1.73

0.81

1.4

1.1

—

Tetraplegia

1.72

0.81

1.3

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.81

0.0

1.2

—

Benign neoplasm: Bone and articular cartilage, unspecified

1.75

0.80

1.3

1.2

—

Abnormality of white blood cells, not elsewhere classified

1.75

0.80

1.5

1.2

—

Gestational [pregnancy-induced] hypertension

278

2534

1.10

0.80

1.2

1.65

15.77

u/ml

—

Colon adenocarcinoma

697

0.82

0.80

1.2

—

0.59

—

Injury of blood vessels at forearm level

0.00

0.80

0.0

1.2

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.80

0.0

1.1

—

Tic disorders

1.74

0.80

1.1

1.2

—

Acute hepatitis A

1.85

0.80

1.5

1.3

—

Malignant neoplasm of gallbladder

0.00

0.80

0.0

1.2

—

Brain astrocytoma, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.3

—

Other abnormal products of conception

362

2226

1.09

0.79

1.3

0.40

20.59

u/ml

—

Adenocarcinomas of cervix, excluding all cancers (controls excluding all cancers)

0.00

0.79

0.0

1.1

—

Female infertility, uterine origin

0.00

0.79

0.0

1.1

—

Pulmonary oedema

1.63

0.78

1.1

—

Brain astrocytoma

0.00

0.78

0.0

1.3

—

Vascular dementia (subcortical)

122

0.57

0.78

1.0

1.1

—

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

584

0.80

0.77

1.1

1.2

—

10.86

—

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

2.25

0.77

1.0

1.2

—

Melanoma in situ

243

1.32

0.77

1.2

—

Fourth [trochlear] nerve palsy

140

1.44

0.77

1.2

—

Unspecified transport accident

1.79

0.77

1.3

1.2

—

Cholinergic urticaria

1.79

0.77

1.0

1.1

—

Adenocarcinomas of cervix

0.00

0.77

0.0

1.3

—

Alcoholic cardiomyopathy

0.00

0.77

0.0

1.3

—

Other specified and unspecified disorders of lens

1.78

0.76

1.2

1.1

—

Other protozoal intestinal diseases

1.53

0.76

1.2

—

Benign neoplasm: Bladder

1.72

0.76

1.8

1.2

—

Injury of nerves at shoulder and upper arm level

1.66

0.76

1.5

1.2

—

Immunodeficiency associated with other major defects

2.14

0.76

1.0

1.2

—

Failure and rejection of transplanted organs and tissues

1.58

0.75

1.2

—

Benign neoplasm: Oesophagus

1.62

0.75

1.3

1.2

—

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

197

0.66

0.75

1.0

1.1

—

Injury of nerves at forearm level

1.58

0.75

1.2

—

Tularaemia

1.62

0.75

1.2

—

Use of riluzole

2.13

0.75

1.2

1.3

—

Pervasive developmental disorders excl. Autism + Asperger

1.70

0.75

1.1

1.2

—

Drug-induced gout

2.12

0.75

1.0

1.2

—

Unspecified protein-energy malnutrition

2.11

0.75

1.0

1.3

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

570

0.80

0.75

1.2

1.1

—

9.22

—

Social disorders starting during childhood or adolecense, excluding more controls

2.10

0.75

1.2

1.3

—

Single spontaneous delivery

379

2175

0.93

0.74

1.2

7.87

9.59

u/ml

—

Slow fetal growth and fetal malnutrition

2.09

0.74

1.2

—

Disorders of phosphorus metabolism and phosphatases

1.88

0.74

1.9

1.2

—

Benign neoplasm: Brain, supratentorial

108

1.49

0.74

1.5

1.2

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

744

1.17

0.74

1.1

1.2

—

23.41

—

Failed induction of labour

460

1.22

0.74

1.5

1.3

—

13.86

—

Other hypertrichosis

2.04

0.73

1.4

1.3

—

Impaction of intestines

1.82

0.73

1.4

1.3

—

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

107

0.56

0.73

1.2

—

Benign neoplasm: Bladder

1.62

0.73

1.8

1.3

—

Donors of organs and tissues

1.56

0.72

1.2

1.3

—

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

653

1.18

0.72

1.1

1.2

—

0.68

—

Drug-induced headache, not elsewhere classified

1.78

0.72

1.4

1.3

—

Supernumerary teeth EXCLUDE clefts and syndromes

1.95

0.71

1.0

1.2

—

Glaucoma suspect

304

2808

1.08

0.71

1.3

1.2

3.00

12.86

u/ml

—

Disorders of other and unspecified cranial nerves

1.95

0.71

1.6

1.3

—

Colectomy operation

125

1103

1.14

0.70

1.2

—

8.85

—

Juvenile Open Angle Glaucoma

1.73

0.70

1.3

—

Bus occupant injured in other and unspecified transport accidents

1.73

0.70

1.0

1.2

—

Transient synovitis

1.72

0.70

1.0

1.2

—

Seminoma of testis, excluding all cancers (controls excluding all cancers)

1.72

0.70

1.1

1.2

—

Female infertility, tubal origin

418

1.23

0.69

1.2

—

30.13

—

Shoulder region

1.54

0.69

1.0

1.2

—

Leiomyoma of uterus

580

3083

1.06

0.69

1.2

19.88

12.63

u/ml

—

Other maternal disorders predominantly related to pregnancy

689

4109

1.06

0.69

1.3

1.2

9.82

12.32

u/ml

0.13

Pedestrian injured in collision with heavy transport vehicle or bus

1.89

0.69

1.0

1.3

—

Intracranial and intraspinal abscess and granuloma

1.66

0.69

1.3

1.2

—

Atypical mycobacterium lung infection

1.61

0.69

1.0

1.2

—

Benign neoplasm: Parotid gland

519

1.20

0.69

1.2

—

10.86

—

Injury of nerves and spinal cord at neck level

127

1.43

0.68

1.1

1.2

—

Complications following infusion, transfusion and therapeutic injection

102

1.48

0.68

1.2

—

Streptococcus and staphylococcus as the cause of diseases classified to other chapters

1.65

0.67

1.0

1.2

—

Carcinoma in situ of skin of lower limb, including hip

119

1.44

0.67

1.1

—

Lifestyle-related condition

1.55

0.66

1.0

1.2

—

Hyperaldosteronism

171

1.35

0.66

1.3

1.2

—

Disorders of puberty

1.55

0.66

1.4

1.3

—

Unspecified renal colic

1.61

0.65

1.0

1.2

—

Seminoma of testis

1.60

0.65

1.1

1.2

—

Benign neoplasm: salivary glands, exclude unknown (D119)

587

1.18

0.65

1.2

—

9.20

—

Exclusion endpoint for clefts

120

1.43

0.65

1.1

1.2

—

Contact urticaria

1.76

0.64

1.0

1.2

—

Malignant neoplasm of liver and intrahepatic bile ducts

154

0.65

0.64

1.1

—

Communicating hydrocephalus

127

0.63

0.64

1.5

1.2

—

Other disorders of carbohydrate metabolism

1.75

0.64

1.2

—

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

1.74

0.64

1.0

1.2

—

Suppurative otitis media, unspecified

155

1.36

0.63

1.2

—

Other acute viral hepatitis

1.53

0.63

1.1

1.2

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

1.56

0.62

1.5

1.2

—

Wide developmental disorders

164

1.35

0.62

1.2

—

Carcinoma in situ of skin of ear and external auricular canal

1.60

0.62

1.2

1.1

—

Carcinoma in situ, bladder

176

0.68

0.62

1.2

1.1

—

Sub-endpoint used in defining T1D endpoints

235

2128

1.09

0.62

1.2

11.30

24.39

u/ml

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

1.69

0.62

1.4

1.3

—

Congenital malformations of posterior segment of eye

1.69

0.62

1.0

1.4

—

Intentional self-harm by hanging, strangulation and suffocation

1.68

0.62

1.2

1.3

—

Neurofibromatosis, type 2

0.00

0.61

0.0

1.2

—

Benign neoplasm: Ciliary body

0.00

0.61

0.0

1.3

—

Injury of blood vessels at hip and thigh level

0.00

0.61

0.0

1.3

—

Chondrosarcoma

0.00

0.61

0.0

1.3

—

Benign neoplasm: Epididymis

0.00

0.61

0.0

1.2

—

Restrictive cardiomyopathy

0.00

0.61

0.0

1.2

—

Other injuries of lower limb, level unspecified

1.58

0.61

1.0

1.3

—

Central retinal artery occlusion

1.49

0.61

1.0

1.2

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.59

0.60

1.3

1.2

—

Carcinoma in situ of skin of trunk

139

1.37

0.60

1.3

1.1

—

ILD medications: acetylcysteine

0.00

0.60

0.0

1.2

—

Emergency coronary revascularization (for ACS)

369

2827

0.94

0.60

1.2

5.85

9.54

u/ml

—

Cerebral amyloid angiopathy

0.00

0.60

0.0

1.0

—

Hereditary ataxia

1.54

0.59

1.2

—

Hyphaema and other vascular disorders of iris and ciliary body

1.45

0.59

1.3

1.2

—

Other degenerative disorders of eyelid and periocular area

0.00

0.59

0.0

1.2

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

0.59

0.0

1.2

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.58

0.0

1.2

—

Acute appendicitis, with complications

168

1529

1.10

0.58

1.2

20.17

25.13

u/ml

—

Varus deformity, not elsewhere classified

1.52

0.58

1.1

1.3

—

Guttate psoriasis

1.47

0.58

1.0

1.2

—

Malaria

1.74

0.58

1.2

—

Respiratory tuberculosis, confirmed

1.47

0.58

1.5

1.2

—

Other rupture of muscle

1.73

0.58

1.2

—

Benign mammary dysplasia

137

1235

1.11

0.58

1.3

1.2

3.97

16.27

u/ml

—

Carcinoma in situ of cervix uteri, exocervix

1.50

0.58

1.0

1.2

—

Benign neoplasm: Pharynx, unspecified

1.50

0.58

1.1

1.2

—

Benign neoplasm: Oesophagus

1.50

0.57

1.3

1.2

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

325

3465

0.94

0.57

1.2

0.65

16.49

u/ml

—

Overjet

140

1.36

0.57

1.3

1.2

—

Precocious central puberty

1.68

0.57

1.0

1.3

—

Oral leukoplakia, including avohilmo

167

1.32

0.57

1.0

1.1

—

Certain zoonotic bacterial diseases

115

1.40

0.57

1.3

1.2

—

Malignant neoplasm of stomach

275

0.76

0.57

1.0

1.1

—

Unequal limb length (acquired)

1.68

0.57

1.2

1.3

—

Other injuries of upper limb, level unspecified

1.52

0.57

1.1

1.2

—

Burn and corrosion of ankle and foot

0.58

0.56

1.0

1.2

—

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.56

1.0

1.2

—

Type 1 diabetes, wide definition, subgroup 2

0.57

0.56

1.4

1.2

—

Dissocial personality disorder

0.56

1.0

1.2

—

Benign neoplasm: Endocrine pancreas

1.64

0.56

1.0

1.3

—

Other bacterial agents as the cause of diseases classified to other chapters

1.55

0.56

1.4

1.2

—

Other adrenocortical overactivity

1.64

0.56

1.3

—

Acute drug-induced interstitial lung disorder

1.64

0.56

1.2

—

Abscess of external ear

1.46

0.56

1.2

—

Tic and related disorders

1.55

0.56

1.1

1.2

—

Malignant neoplasm of colon

891

0.87

0.55

1.2

—

6.29

—

Exposure to other and unspecified forces of nature

1.60

0.55

1.0

1.3

—

Dependence on enabling machines and devices, not elsewhere classified

1.50

0.54

1.2

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.48

0.54

1.3

1.2

—

Benign neoplasm: Parotid gland

534

1.16

0.53

1.2

—

9.20

—

Benign neoplasm: Rectum/anal canal icd-9

1.55

0.53

1.8

1.2

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

1.44

0.53

1.5

1.2

—

Foreign body entering into or through eye or natural orifice

488

1.17

0.53

1.2

—

10.96

—

Congenital musculoskeletal deformities of head, face, spine and chest

1.53

0.53

1.0

1.2

—

Haemorrhagic and haematological disorders of fetus and newborn

1.41

0.53

1.0

1.3

—

Benign neoplasm: Brain, supratentorial

117

1.38

0.52

1.5

1.1

—

Malignant neoplasm of other connective and soft tissue

132

0.68

0.52

1.2

—

Other congenital malformations of tongue, mouth and pharynx

1.52

0.51

1.1

1.2

—

Mild mental retardation

157

0.70

0.51

1.2

—

Congenital malformations of the nervous system

135

1.34

0.51

1.4

1.2

—

Use of rotigotine

1.48

0.51

1.3

1.2

—

Abnormal findings on diagnostic imaging of breast

101

1.40

0.50

1.1

1.2

—

Respiratory distress of newborn

1.50

0.50

1.0

1.3

—

Fasciculation

1.44

0.50

1.3

1.2

—

Malignant neoplasm

925

5684

0.96

0.49

1.2

0.94

15.29

u/ml

3.50

Progressive vascular leukoencephalopathy

145

1.32

0.49

1.2

1.1

—

Localized adiposity

1.54

0.49

1.4

1.2

—

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

108

0.64

0.49

1.0

1.1

—

Leukaemia of unspecified cell type

1.53

0.48

1.0

1.2

—

Benign neoplasm: Parathyroid gland

1.46

0.48

1.3

1.2

—

Other abnormal auditory perceptions

1.46

0.48

1.1

1.2

—

Human immunodeficiency virus [HIV] disease resulting in other conditions

111

0.63

0.48

1.0

1.1

—

Other congenital malformations of limb(s)

1.50

0.48

1.0

1.3

—

Mixed disorders of conduct and emotions

128

1.33

0.48

1.0

1.2

—

Biguanides

992

5911

1.03

0.48

1.2

12.28

11.41

u/ml

0.05

Fibrosis of liver

1.47

0.47

1.0

1.2

—

Delivery

391

2181

0.95

0.47

1.2

9.10

9.59

u/ml

—

Neonatal jaundice from other and unspecified causes

1.47

0.46

1.0

1.2

—

Carcinoma in situ of breast, intraductal

686

0.87

0.46

1.2

—

32.07

—

Neuroendocrine tumor and carcinoma of lung

1.44

0.46

1.1

1.2

—

Leukaemia of unspecified cell type

1.44

0.46

1.0

1.2

—

Other congenital malformations, not elsewhere classified

1.44

0.46

1.0

1.2

—

Melanoma in situ of trunk

0.61

0.46

1.0

1.2

—

123

1.32

0.45

1.2

—

Malignant neoplasm of bone and articular cartilage

1.41

0.45

1.4

1.2

—

Colitis, primary sclerosing, strict definition

1.46

0.44

1.1

1.2

—

Neuroendocrine tumor and carcinoma of lung, excluding all cancers (controls excluding all cancers)

1.38

0.44

1.1

—

Other and unspecified disorders of psychological development

1.38

0.44

1.0

1.2

—

Ankyloglossia

1.45

0.44

1.1

1.2

—

Alcohol use disorder, ICD-based

303

3201

0.95

0.43

1.2

0.65

16.49

u/ml

—

Other disorders of optic disc

0.65

0.42

1.2

—

Injury of blood vessels at abdomen, lower back and pelvis level

1.58

0.42

1.0

1.2

—

Other congenital malformations of kidney

1.58

0.42

1.0

1.2

—

Apocrine sweat disorders, other sweat gland disorders

1.58

0.42

1.6

1.2

—

Other and unspecified mental retardation

0.66

0.42

1.2

1.1

—

Cardiomyopathy in other diseases

1.58

0.42

1.0

1.1

—

Nosocomial condition (hospital)

1.58

0.42

1.0

1.2

—

Carcinoma in situ of cervix uteri, exocervix

1.42

0.42

1.0

1.2

—

Gilbert syndrome

1.42

0.42

1.6

1.1

—

Anuria and oliguria

1.57

0.42

1.2

—

Other bursitis of elbow

1.57

0.42

1.4

1.2

—

Inhalation and ingestion of food causing obstruction of respiratory tract

1.41

0.42

1.3

1.2

—

Burns and corrosions of multiple and unspecified body regions

131

1.30

0.42

1.1

1.2

—

Perioral dermatitis, drug-induced

0.00

0.42

0.0

1.1

—

Diphtheria

0.00

0.42

0.0

1.3

—

Benign neoplasm: Pharynx, unspecified

1.39

0.42

1.1

1.2

—

Malignant neoplasm of vagina

0.00

0.42

0.0

1.2

—

1.39

0.42

1.0

1.2

—

Disorders of puberty, all

1.36

0.41

1.4

1.3

—

Craniosynostosis EXCLUDE syndromes

0.00

0.41

0.0

1.3

—

Malignant neoplasm of anus and anal canal

1.53

0.41

1.4

1.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

1.53

0.41

1.6

1.2

—

Other haemoglobinopathies

0.00

0.41

0.0

1.3

—

Disorders of purine and pyrimidine metabolism

1.53

0.41

1.4

1.3

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.00

0.41

0.0

1.1

—

Small kidney of unknown cause

0.00

0.41

0.0

1.3

—

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

1.53

0.41

1.0

1.2

—

Acute lymphocytic leukaemia, helper endpoint

1.53

0.41

1.0

1.2

—

Acute lymphocytic leukaemia

1.53

0.41

1.0

1.1

—

Adenocarcinoma of small intestine

0.00

0.41

0.0

1.2

—

Traumatic amputation of ankle and foot

0.00

0.41

0.0

1.4

—

Benign neoplasm: Epididymis

0.00

0.41

0.0

1.1

—

Other benign neoplasm of uterus: Corpus uteri

1.37

0.41

1.3

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

1.36

0.41

1.0

1.2

—

Tuberous sclerosis 1

0.00

0.41

0.0

1.2

—

Carcinoma in situ of oral cavity

0.00

0.41

0.0

1.3

—

Malignant neoplasm of prostate

226

1520

0.94

0.41

1.1

1.2

—

10.82

—

Mental and behavioural disorders due to use of volatile solvents

0.00

0.41

0.0

1.3

—

Optic atrophy

114

1.32

0.41

1.1

1.2

—

Other cestode infections

0.00

0.41

0.0

1.2

—

Alzheimer’s disease (undefined)

0.00

0.40

0.0

1.1

—

Familial erythrocytosis

1.48

0.40

1.6

1.2

—

Defect, injury or illness of neck

1.48

0.40

1.2

1.3

—

Autism

123

1.31

0.40

1.2

1.3

—

Pseudomembranous colitis

1.34

0.40

1.5

1.2

—

Adult respiratory distress syndrome

1.34

0.40

1.4

1.2

—

Osteogenesis imperfecta

0.00

0.40

0.0

1.3

—

Post-traumatic hydrocephalus, unspecified

0.00

0.40

0.0

1.2

—

Benign neoplasm: Skin of scalp and neck

150

1.27

0.40

1.2

—

Carcinoma in situ of middle ear and respiratory system

0.00

0.40

0.0

1.2

—

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

1.32

0.40

1.0

1.1

—

Abnormal reflex

1.44

0.39

1.2

1.3

—

Adenocarcinoma of small intestine, excluding all cancers (controls excluding all cancers)

0.00

0.39

0.0

1.2

—

Renal cell carcinoma of kidney

182

0.77

0.39

1.0

1.2

—

Benign neoplasm: Ciliary body

0.00

0.39

0.0

1.2

—

Abnormal spermatozoa

607

1.12

0.39

1.1

1.2

—

20.60

—

Other mental disorders due to brain damage and dysfunction and to physical disease

664

1.12

0.39

1.2

—

7.97

—

Hypothyroidism due to medicaments and other exogenous substances

1.35

0.38

1.1

1.3

—

Hypertrophy of tongue papillae

1.36

0.38

1.0

1.2

—

Other specified congenital malformation syndromes affecting multiple systems

1.33

0.37

1.0

1.2

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

111

0.72

0.37

1.4

1.2

—

Other and unspecified degenerative diseases of nervous system

114

0.70

0.37

1.4

1.2

—

Inguinal hernia, unilateral

152

1.25

0.37

1.1

—

Femoral hernia, unilateral

152

1.25

0.37

1.1

—

Inguinal of femoral hernia, unilateral

152

1.25

0.37

1.1

—

Carcinoma in situ of breast, intraductal

672

0.89

0.36

1.2

—

26.33

—

Placenta praevia

375

0.85

0.36

1.1

1.3

—

0.40

—

Left hemicolectomy

135

0.74

0.36

1.0

1.2

—

Contact with hypodermic needle

1.48

0.36

1.5

1.2

—

Congenital malformations of spine and bony thorax

1.48

0.36

1.2

—

Secondary parkinsonism+Parkinsonism in other disease

146

0.75

0.36

1.5

1.2

—

Phakomatoses, not elsewhere classified

0.65

0.36

1.2

—

Melanoma in situ of upper limb, including shoulder

1.44

0.36

1.5

1.2

—

Emotional disorders starting during childhood or adolescence

307

1.17

0.36

1.1

1.2

—

Motor disorders

0.64

0.36

1.0

1.2

—

Complications of labour and delivery

692

3984

0.97

0.35

1.3

1.2

28.76

9.10

u/ml

—

Other congenital malformations of ear

0.63

0.35

1.0

1.3

—

Neuroendocrine tumor and carcinoma of small intestine

0.62

0.35

1.0

1.2

—

Malignant neoplasm of small intestine

122

0.73

0.35

1.0

1.2

—

Blood alcohol or alcohol intoxication level

144

1.25

0.35

1.0

1.2

—

Benign neoplasm: Endocrine pancreas

1.41

0.35

1.0

1.2

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

1.37

0.34

1.0

1.2

—

Crystalline deposits in vitreous body

1.37

0.34

1.3

1.2

—

Non-Hodgkin lymphoma, all

211

0.80

0.34

1.2

1.1

—

Somnolence

1.35

0.34

1.1

1.2

—

Benign neoplasm: other/unspecified salivary gland

163

1.23

0.34

1.3

1.2

—

Patellar tendinitis

1.35

0.34

1.3

1.2

—

Contact with other hot metals

1.33

0.34

1.1

1.2

—

Haemorrhagic disorder due to circulating anticoagulants

1.34

0.34

1.2

—

Volvulus

145

1.25

0.34

1.2

—

Amyloidosis, other/unspecified

109

1.29

0.33

1.1

1.2

—

Helminthiases

118

1.28

0.33

1.0

1.2

—

Autism spe

118

1.28

0.33

1.2

1.3

—

Melanoma in situ of upper limb, including shoulder

1.31

0.33

1.5

1.2

—

Acute myeloid leukaemia

1.31

0.33

1.2

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

0.67

0.33

1.0

1.2

—

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

1.33

0.32

1.4

1.1

—

Assault by sharp object

1.31

0.32

1.4

1.2

—

Burns and corrosions of multiple body regions

1.33

0.31

1.1

1.2

—

Secondary parkinsonism

142

0.77

0.31

1.5

1.2

—

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

1.30

0.30

1.0

1.2

—

Exophthalmic conditions

1.34

0.30

1.0

1.1

—

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

401

2870

0.96

0.30

1.2

0.60

15.96

u/ml

—

Benign neoplasm: Parathyroid gland

1.32

0.30

1.3

1.2

—

Torsion of testis

1.34

0.30

1.4

1.1

—

Late syphilis

1.32

0.30

1.1

1.2

—

Benign neoplasm: Nasopharynx

1.28

0.30

1.0

1.2

—

Infections of breast associated with childbirth

287

1.15

0.30

1.5

1.3

—

9.08

—

Carcinoma in situ of skin, other sites/unspecified

1.28

0.30

1.6

1.2

—

Rheumatic valve diseases

111

1.27

0.30

1.2

—

Persons encountering health services in circumstances related to reproduction

565

3712

1.03

0.30

1.2

26.86

14.82

u/ml

—

Carcinoma in situ of skin of trunk

157

1.21

0.29

1.3

1.1

—

Acute mastoiditis

1.26

0.29

1.1

1.2

—

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

141

0.78

0.29

1.0

1.1

—

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

107

0.74

0.29

1.3

1.1

—

Malignant neoplasm of tongue

106

0.75

0.29

1.0

1.2

—

Accidental poisoning by and exposure to alcohol

106

0.75

0.29

1.4

1.2

—

Ankle and foot

1.23

0.29

1.1

1.2

—

Disorders of globe

139

1.23

0.29

1.1

1.2

—

Other congenital malformations of intestine

1.23

0.29

1.7

1.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

121

1.24

0.28

1.1

1.2

—

Other benign neoplasm of uterus: Corpus uteri

1.30

0.28

1.3

1.2

—

Burn and corrosion of head and neck

129

0.77

0.28

1.4

1.2

—

False labour

325

1963

1.04

0.28

1.2

1.3

15.57

17.16

u/ml

—

Malignant neoplasm of oral cavity

194

0.82

0.28

1.1

1.2

—

Degeneration of the brain due to alcohol

116

0.77

0.27

1.1

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

1.24

0.27

1.0

1.2

—

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

512

3394

1.03

0.27

1.2

0.60

15.17

u/ml

—

Atypical virus infections of central nervous system

0.70

0.26

1.4

1.2

—

Melanoma in situ of trunk

0.69

0.26

1.0

1.2

—

Injury of nerves at lower leg level

0.68

0.26

1.6

1.2

—

Viral infections of central nervous system, not elsewhere classified/unspecified

0.68

0.26

1.0

1.2

—

Specific developmental disorder of motor function

0.69

0.26

1.0

1.4

—

Malignant neoplasm of larynx

0.69

0.26

1.2

—

Conotruncal defects

0.68

0.26

1.4

1.2

—

Mandibular prognathia AND surgery (LeFortI or BSSO or LeFortI AND BSSO), including avohilmo

0.67

0.26

1.8

1.3

—

Benign neoplasm: Appendix

1.26

0.26

1.0

1.2

—

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

969

5608

1.02

0.25

1.2

0.95

15.09

u/ml

3.48

Melanocytic naevi of lower limb, including hip

301

1.13

0.25

1.6

1.2

—

10.92

—

Benign neoplasm: Skin of scalp and neck

160

1.19

0.25

1.2

—

Respiratory conditions due to other external agents

123

1.22

0.25

1.1

—

Oesophageal obstruction

188

1.17

0.25

1.0

1.2

—

Benign neoplasm: Appendix

1.22

0.25

1.0

1.1

—

Acquired absence of organs, not elsewhere classified

1.22

0.25

1.2

—

Malignant neoplasm, wide definition for exclusion

969

5610

1.02

0.25

1.2

0.95

15.09

u/ml

3.48

518

4513

1.03

0.25

1.2

0.61

16.15

u/ml

—

Non-allergic asthma

579

1.09

0.25

1.3

1.2

—

9.27

—

Amputation of thigh

105

1.24

0.24

1.3

1.1

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

335

0.88

0.24

1.1

1.2

—

Malignant melanoma

101

947

1.07

0.24

1.2

—

9.57

—

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

412

2923

0.97

0.24

1.2

0.60

15.96

u/ml

—

Gender identity disorders

1.17

0.24

1.2

1.3

—

Alcoholic gastritis

1.17

0.24

1.2

1.1

—

Mental and behavioural disorders due to alcohol

393

3944

0.97

0.24

1.2

0.65

15.49

u/ml

—

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

180

0.83

0.24

1.1

1.2

—

Other diseases of appendix

0.72

0.24

1.2

—

Superficial injury of neck

115

1.22

0.23

1.1

1.2

—

Delayed milestone in childhood

1.26

0.23

1.3

—

Pedal cyclist injured in collision with motor vehicle

199

1.16

0.23

1.2

—

Marfan's syndrome

1.32

0.23

1.0

1.2

—

Complications peculiar to reattachment and amputation

1.32

0.23

1.2

—

Cardiomyopathy, Hypertrophic obstructive

106

1.23

0.23

1.2

—

Malignant neoplasm of floor of mouth

1.29

0.23

1.2

—

Alcohol use disorder, Swedish definition

456

4118

1.03

0.23

1.2

0.61

13.98

u/ml

—

Obstructive hydrocephalus

0.75

0.22

1.9

1.2

—

Glaucoma secondary to eye trauma

1.26

0.22

1.0

1.2

—

Exposure to excessive heat of man-made origin

1.25

0.22

1.2

1.3

—

Villonodular synovitis (pigmented)

1.25

0.22

1.0

1.2

—

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

967

5609

1.02

0.22

1.2

0.94

15.09

u/ml

3.48

Pyogenic granuloma

0.73

0.22

1.0

1.2

—

Intracranial laceration and haemorrhage due to birth injury

0.00

0.22

0.0

1.3

—

Burn and corrosion, body region unspecified

1.22

0.22

1.0

1.2

—

Congenital malformations of great arteries

123

1.20

0.22

1.1

1.2

—

Collapsed vertebra, not elsewhere classified

1.22

0.22

1.8

1.1

—

Albinism

0.00

0.22

0.0

1.1

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.22

0.0

1.1

—

Localized hypertrichosis

0.00

0.22

0.0

1.3

—

Other hypertrophic osteoarthropathy

0.00

0.22

0.0

1.2

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.22

0.0

1.1

—

Malignant neoplasm of trachea, excluding all cancers (controls excluding all cancers)

0.00

0.22

0.0

1.0

—

Dysplastic lesion of the vagina of unknown severity

0.00

0.22

0.0

1.4

—

Vascular diseases of the intestine

191

1.15

0.21

1.1

—

Congenital glaucoma

0.00

0.21

0.0

1.2

—

Other and unspecified hereditary haemolytic anaemias

0.00

0.21

0.0

1.5

—

Corrosions classified according to extent of body surface involved

0.00

0.21

0.0

1.4

—

Malignant neoplasm of placenta, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.1

—

Other congenital malformations of eye

0.00

0.21

0.0

1.2

—

Brain mixed glioma

0.00

0.21

0.0

1.4

—

Brain mixed glioma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Drug-induced autoimmune haemolytic anaemia

0.00

0.21

0.0

1.5

—

Congenital absence, atresia and stenosis of large intestine

0.00

0.21

0.0

1.0

—

Use of bromocriptine

0.00

0.21

0.0

1.2

—

Ependymoma, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.0

—

Ependymoma

0.00

0.21

0.0

1.2

—

Traumatic amputation of part of head

0.00

0.21

0.0

1.3

—

Other congenital malformations of respiratory system

0.00

0.21

0.0

1.4

—

Use of trihexyphenidyl

0.00

0.21

0.0

1.3

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.21

0.0

1.2

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.21

0.0

1.2

—

Other hereditary haemolytic anaemias

1.19

0.21

1.0

1.3

—

Thoracic root disorders

0.00

0.21

0.0

1.2

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

1.0

—

Cardiomyopathy due to drugs and other external agents

0.00

0.21

0.0

1.0

—

Benign neoplasm: Liver/bile ducts (ICD-9)

0.00

0.21

0.0

1.1

—

Carcinoma in situ of oral cavity

0.00

0.21

0.0

1.4

—

Nightmares

0.00

0.21

0.0

1.3

—

Malignant neoplasm of accessory sinuses

0.00

0.21

0.0

1.4

—

Disorders of sexual preference

0.00

0.21

0.0

1.2

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

0.00

0.21

0.0

1.2

—

Social disorders starting during childhood or adolescence

1.19

0.21

1.2

—

Congenital malformations of lung

0.00

0.21

0.0

1.3

—

0.00

0.21

0.0

1.1

—

Inhalation of gastric contents

0.00

0.21

0.0

1.5

—

Burn and corrosion of respiratory tract

0.00

0.21

0.0

1.2

—

Benign neoplasm of mesothelial tissue

0.00

0.21

0.0

1.2

—

Disorders of vagus nerve

0.00

0.21

0.0

1.2

—

Disorders of tyrosine metabolism

0.00

0.21

0.0

1.2

—

Intentional self-harm by smoke, fire and flames

0.00

0.21

0.0

1.1

—

Malignant neoplasm of ureter

0.00

0.21

0.0

1.2

—

Colorectal neuroendocrine tumor and carcinoma

105

0.76

0.21

1.3

1.2

—

Cerebral palsy

105

0.76

0.21

1.0

1.2

—

Congenital absence, atresia and stenosis of small intestine

0.00

0.21

0.0

1.2

—

Obstetric embolism

0.00

0.21

0.0

1.2

—

Benign neoplasm: Cornea

0.00

0.21

0.0

1.2

—

Benign neoplasm: Cornea

0.00

0.21

0.0

1.3

—

Carcinoma in situ of larynx

0.00

0.21

0.0

1.2

—

Intentional self-harm by drowning and submersion

0.00

0.21

0.0

1.3

—

Cerebral oedema

0.00

0.21

0.0

1.2

—

Periodontosis

0.00

0.21

0.0

1.2

—

Sleep terrors [night terrors]

0.00

0.21

0.0

1.2

—

Choroidal haemorrhage and rupture

0.00

0.21

0.0

1.1

—

Traumatic cerebral oedema

0.00

0.21

0.0

1.2

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.21

0.0

1.3

—

Drug-induced acute pancreatitis

0.00

0.20

0.0

1.3

—

Polyp of middle ear

0.00

0.20

0.0

1.2

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

123

0.81

0.20

1.1

1.2

—

Malignant neoplasm of spinal cord, cranial nerves and other parts of central nervous system

0.00

0.20

0.0

1.3

—

Bradycardia, unspecified, drug-induced

0.00

0.20

0.0

1.2

—

Melanocytic naevi of other and unspecified parts of face

428

0.91

0.20

1.2

—

10.92

—

Disorders of magnesium metabolism

1.23

0.20

1.0

1.2

—

Mixed specific developmental disorders

104

0.80

0.20

1.1

1.2

—

malignant neoplasm of male genital organs

239

1572

0.96

0.20

1.1

1.2

—

10.82

—

Benign neoplasm: Rectum/anal canal icd-9

1.23

0.20

1.8

1.1

—

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

1005

0.94

0.20

1.2

—

16.93

—

Injury of muscle and tendon at forearm level

114

0.79

0.20

1.0

1.1

—

Degeneration of nervous system due to alcohol

115

0.78

0.20

1.1

—

Hyperprolactinaemia, drug-induced

1.21

0.20

1.0

1.2

—

Dissection of aorta

155

1.16

0.20

1.2

1.1

—

Benign neoplasm: Anus and anal canal

174

1.15

0.19

1.1

—

Acute myringitis

1.16

0.19

1.3

1.2

—

Acute myeloid leukaemia, helper endpoint

1.16

0.19

1.2

1.1

—

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.16

0.19

1.2

1.1

—

Sexual dysfunction

1.24

0.19

1.1

1.2

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

1.24

0.19

1.6

1.2

—

Morphin

1.24

0.19

1.0

1.1

—

Lymphangioma, anys site

1.13

0.19

1.5

1.2

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.24

0.18

1.1

1.2

—

Congenital malformations of genital organs

769

1.06

0.18

1.2

—

5.64

—

Toxic effect of alcohol

132

0.83

0.18

1.4

1.2

—

Benign neoplasm: Nasopharynx

1.21

0.18

1.0

1.1

—

Occlusion and stenosis of arteries, not leading to stroke

1.21

0.18

1.1

—

Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours

1.19

0.18

1.0

1.2

—

Symptoms and signs involving appearance and behaviour

1.19

0.18

1.0

1.2

—

Other and unspecified hydrocephalus

121

0.82

0.18

1.4

1.2

—

1.17

0.18

1.0

1.2

—

Spondylopathies in diseases classified elsewhere

1.17

0.18

1.6

1.2

—

Acquired stenosis of external ear canal

1.13

0.17

1.0

1.2

—

Respiratory tuberculosis, clinically confirmed

1.13

0.17

1.4

1.2

—

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

922

0.95

0.17

1.2

—

11.43

—

Carcinoma in situ of breast, lobular

0.74

0.17

1.2

—

Carcinoid syndrome

1.11

0.17

1.0

1.2

—

Carcinoma in situ of breast, lobular

0.73

0.17

1.2

1.1

—

Malignant neoplasm of parotid gland, excluding all cancers (controls excluding all cancers)

0.75

0.17

1.2

—

Tarsal tunnel syndrome

0.75

0.17

1.6

1.1

—

Assault by other specified means

0.73

0.17

1.2

—

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

129

1.17

0.17

1.0

1.2

—

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

190

1180

0.97

0.17

1.1

1.2

—

12.53

—

Striae atrophicae

0.72

0.17

1.4

1.2

—

Gastrojejunal ulcer

1.18

0.16

1.0

1.2

—

Postdysenteric arthropathy

1.15

0.16

1.0

1.2

—

Other congenital malformations of nervous system

1.15

0.16

1.4

1.2

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

505

2913

1.02

0.16

1.2

1.3

10.80

12.84

u/ml

—

Other and unspecified injuries of thorax

111

1.17

0.16

1.4

1.1

—

Other specified and unspecified strabismus

1.10

0.16

1.3

1.2

—

Sequelae of tuberculosis

1.10

0.15

1.0

1.1

—

Myeloid leukaemia

149

1.14

0.15

1.1

1.2

—

Exposure to other specified electric current

0.76

0.15

1.0

1.2

—

Sequelae of other accidents

1.21

0.15

1.3

1.2

—

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

1.11

0.15

1.2

1.1

—

Hereditary retinal dystrophy

1.09

0.14

1.6

1.2

—

Open wound of thorax

1.19

0.14

1.4

1.2

—

Convergence insufficiency and excess

0.78

0.14

1.1

1.2

—

Any event in cancer register

997

5988

0.99

0.14

1.2

0.99

16.12

u/ml

3.59

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

442

2972

1.02

0.14

1.2

0.60

15.96

u/ml

—

Cyst of Bartholin Gland

304

1.09

0.14

1.3

1.2

—

10.92

—

Human immunodeficiency virus [HIV] disease

122

1.15

0.14

1.0

1.1

—

Benign neoplasm: Peripheral nerves and autonomic nervous system

100

0.80

0.13

1.4

1.2

—

Coronary revascularization (ANGIO or CABG)

330

2351

0.98

0.13

1.2

6.41

12.29

u/ml

—

Benign neoplasm: Skin of lip

1.17

0.13

1.0

1.1

—

Mandibular prognathia

106

0.85

0.13

1.7

1.2

—

Carcinoma in situ of other and unspecified digestive organs

138

0.87

0.13

1.0

1.1

—

Other disorders of binocular movement

142

1.13

0.12

1.1

1.2

—

Anxious personality disorder

123

1.14

0.12

1.0

1.2

—

Hydrocele

561

1.05

0.12

1.1

—

24.78

—

Retinoschisis and retinal cysts

143

1.12

0.11

1.2

1.1

—

Benign neoplasm: Skin of lower limb, including hip

172

1.11

0.11

1.5

1.2

—

Burn and corrosion of trunk

172

1.11

0.11

1.2

—

Exposure to smoke, fire and flames

126

0.87

0.11

1.4

1.2

—

124

1.13

0.11

1.2

1.1

—

Malnutrition

105

1.15

0.11

1.0

1.2

—

Malignant neoplasm, without specification of site

136

0.88

0.11

1.4

1.2

—

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

660

1.04

0.10

1.2

—

0.78

—

Behavioural disorders

115

1.13

0.10

1.0

1.2

—

Conduct disorder

115

1.13

0.10

1.0

1.2

—

Benign neoplasm: Skin of lip

1.15

0.10

1.0

1.2

—

Secondary polycythaemia

125

0.88

0.10

1.2

1.1

—

Thyrotoxicosis with toxic multinodular goitre

388

1.06

0.10

1.1

1.2

—

10.84

—

Exposure to uncontrolled fire in building or structure

1.14

0.10

1.2

—

Injury of blood vessels at wrist and hand level

1.09

0.09

1.0

1.3

—

Cauda equina syndrome

1.15

0.09

1.1

1.2

—

Cholesteatoma of external ear

1.07

0.09

1.2

—

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

615

0.96

0.09

1.2

—

25.09

—

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

116

1.12

0.09

1.5

1.2

—

Postprocedural disorders of ear and mastoid process, not elsewhere classified

1.04

0.09

1.0

1.2

—

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

1.11

0.09

1.0

1.1

—

Liveborn infants according to place of birth

1.09

0.09

1.7

1.2

—

Malignant neoplasm of vulva

1.07

0.08

1.3

1.2

—

Malignant neoplasm of heart, mediastinum and pleura

1.07

0.08

1.5

1.1

—

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

1.05

0.08

1.2

—

Other and specified injuries of hip and thigh

136

1.10

0.08

1.2

—

Motor disorders, excluding more controls

0.82

0.08

1.0

1.4

—

Malignant melanoma, excluding all cancers (controls excluding all cancers)

119

1220

0.97

0.08

1.2

—

15.82

—

Fibrosarcoma, excluding all cancers (controls excluding all cancers)

0.78

0.08

1.0

1.1

—

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

1.08

0.08

1.4

1.2

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

1.06

0.08

1.1

1.2

—

Carcinoma in situ of skin, other sites/unspecified

1.06

0.08

1.6

1.1

—

Melanocytic naevi of eyelid, including canthus

1.05

0.08

1.1

1.2

—

Evidence of alcohol involvement determined by level of intoxication

1.03

0.08

1.0

1.2

—

Previous suicide attempt

0.85

0.07

1.0

1.2

—

Benign neoplasm: Spinal cord

1.13

0.07

1.1

1.2

—

Contact with lifting and transmission devices, not elsewhere classified

1.12

0.07

1.1

1.2

—

Tibial collateral bursitis [Pellegrini-Stieda]

0.81

0.07

1.2

—

Carcinoma in situ of colon

1.05

0.07

1.0

1.2

—

Personal history of risk-factors, not elsewhere classified

1.05

0.07

1.0

1.2

—

Injury of intra-abdominal organs

143

0.91

0.07

1.0

1.2

—

Oral leukoplakia

108

1.11

0.07

1.1

1.2

—

Chronic myeloproliferative disease

0.85

0.07

1.1

1.2

—

Venous complications and haemorrhoids in the puerperium

0.83

0.07

1.7

1.1

—

Fracture of femur

154

1433

0.98

0.07

1.3

1.2

0.54

6.99

u/ml

—

Malignant neoplasm of other and unspecified parts of tongue

0.82

0.07

1.0

1.2

—

Crushing injury of wrist and hand

0.82

0.07

1.0

1.2

—

Carcinoma in situ of cervix uteri

748

1.03

0.07

1.3

1.2

—

5.64

—

Other specified and unspecified disorders of eyelid

1.07

0.07

1.2

1.1

—

Memory loss

580

1.04

0.07

1.2

—

0.64

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1.06

0.07

1.3

1.1

—

Myeloid leukaemia

157

1.08

0.07

1.1

—

Benign neoplasm of male genital organs

1.06

0.07

1.1

—

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

1.05

0.07

1.4

1.2

—

Other disorders of central nervous system

1.05

0.07

1.2

—

Other assisted single delivery

163

0.92

0.07

1.4

1.3

—

0.58

—

Benign neoplasm of male genital organs

1.03

0.07

1.1

—

Malignant neoplasm of tonsil

1.02

0.07

1.7

1.2

—

Non-small cell lung cancer

907

1.03

0.07

1.2

—

11.36

—

Other disorders of binocular vision

0.88

0.07

1.3

1.2

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

132

0.91

0.06

1.1

1.2

—

Multiple myeloma

132

0.91

0.06

1.1

1.2

—

Evidence of alcohol involvement determined by blood alcohol level

1.11

0.06

1.0

1.2

—

Adhesive middle ear disease

1.11

0.06

1.1

1.2

—

Basal cell carcinoma

440

3473

1.01

0.06

1.2

0.60

14.69

u/ml

—

Fall involving bed

139

1.08

0.05

1.0

1.2

—

Basal cell carcinoma, including avohilmo

455

3553

1.01

0.05

1.2

0.60

14.04

u/ml

—

Carcinoma in situ of cervix uteri

752

1.02

0.05

1.3

1.2

—

7.91

—

Charcot foot

100

1.10

0.05

1.1

—

Malignant melanoma of skin

713

1.02

0.05

1.3

1.2

—

7.94

—

477

4351

1.01

0.04

1.2

0.61

15.19

u/ml

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

453

0.97

0.04

1.2

—

6.97

—

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

131

1.07

0.03

1.4

1.1

—

Assault by blunt object

1.09

0.03

1.1

1.2

—

Benign neoplasm: Vagina

102

1.08

0.03

1.0

1.2

—

Corneal degeneration

102

1.08

0.03

1.1

1.2

—

Hypertrophic cardiomyopathy

241

1.04

0.02

1.1

1.2

—

Contact with sharp object, undetermined intent

132

1.06

0.02

1.4

1.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

429

3372

1.00

0.02

1.1

1.2

0.60

14.69

u/ml

—

Coronary angioplasty

259

1998

0.99

0.01

1.2

6.64

13.96

u/ml

—

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

153

1.05

0.01

1.0

1.2

—

Malignant neoplasm of skin

501

3770

1.00

0.00

1.2

0.60

13.00

u/ml

—

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

202

1233

1.00

0.00

1.1

1.2

—

13.76

—

Cardiac arrest

277

1.00

0.00

1.1

1.2

—

29.30

—

Other benign neoplasms of uterus

375

1.01

0.00

1.3

1.2

—

0.54

—

Arterial embolism and thrombosis of lower extremity artery

172

0.99

0.00

1.0

1.1

—

Open wound of shoulder and upper arm

115

1.04

0.00

1.2

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

146

1.03

0.00

1.4

1.2

—

Carcinoma in situ of breast, other/unspecified

103

0.97

0.00

1.1

1.2

—

Benign neoplasm: Vagina

113

0.97

0.00

1.0

1.1

—

Malignant neoplasm of oropharynx

1.02

0.00

1.6

1.2

—

Use of amantadine

112

0.98

0.00

1.1

1.2

—

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

112

0.98

0.00

1.5

1.2

—

Exposure to other and unspecified man-made environmental factors

101

0.99

0.00

1.0

1.2

—

Benign neoplasm: Spinal cord

109

1.01

0.00

1.1

1.2

—

Foreign body in ear

129

1.01

0.00

1.3

1.2

—

Other inflammation of vagina/vulva

281

1.00

0.00

1.2

—

7.83

—

Motorcycle rider injured in noncollision transport accidents

163

0.98

0.00

1.1

1.2

—

Maternal care for cervical incompetence

315

0.98

0.00

1.1

1.2

—

0.58

—

Benign neoplasm of other and unspecified female genital organs

325

1.02

0.00

1.2

—

10.84

—

Benign neoplasm of other and unspecified female genital organs

325

1.02

0.00

1.2

—

18.60

—

Refsum disease

0.00

0.0

1.3

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.1

—

Carcinoma in situ of lip, excluding all cancers

0.00

0.0

1.0

—

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx

0.00

0.0

1.2

—

Benign neoplasm: Spinal meninges

0.88

0.00

1.4

1.2

—

Exclusion endpoint for supernumerary teeth

0.97

0.00

1.0

1.2

—

Peptic ulcer

0.91

0.00

1.2

1.1

—

Melanocytic naevi of lip

0.97

0.00

1.5

1.2

—

Selective deficiency of immunoglobulin M [IgM]

0.00

0.0

1.4

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.3

—

Liposarcoma, excluding all cancers (controls excluding all cancers)

0.91

0.00

1.0

1.2

—

Use of pergolide

0.00

0.0

1.3

—

Mantle cell lymphoma

0.98

0.00

1.4

1.2

—

Myiasis

0.00

0.0

1.4

—

Contact with other specified venomous plants

0.00

0.0

1.1

—

Drug-induced aplastic anaemia

0.00

0.0

1.4

—

Other chorioretinal disorders in diseases classified elsewhere

0.00

0.0

1.5

—

Glanders and melioidosis

0.00

0.0

1.0

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

0.0

1.3

—

Injury of blood vessels at ankle and foot level

0.00

0.0

1.3

—

Other disorders of bone development and growth

0.00

0.0

1.0

—

Bladder disorders in in diseases classified elsewhere

0.00

0.0

1.0

—

Carcinoma in situ of anus and anal canal

0.00

0.0

1.4

—

Chromomycosis and phaeomycotic abscess

0.00

0.0

1.2

—

Hyperalimentation, other specified

0.00

0.0

1.0

—

Drug-induced hypoglycaemia without coma

1.01

0.00

1.3

1.2

—

Disorders of glycoprotein metabolism, other/unspecified

0.00

0.0

1.2

—

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

0.91

0.00

1.2

—

Use of benzatropine

0.00

0.0

1.5

—

Noonan syndrome

0.00

0.0

1.2

—

Von Hippel-Lindau syndrome

0.00

0.0

1.3

—

Other osteochondrodysplasias

0.91

0.00

1.0

1.3

—

Hirsprung

0.00

0.0

1.1

—

Reduction defects of unspecified limb

0.00

0.0

1.3

—

Other congenital malformations of posterior segment of eye (coloboma)

0.00

0.0

1.2

—

Other congenital malformations of female genitalia

0.85

0.00

1.4

1.2

—

Disorders of fructose metabolism

0.00

0.0

1.3

—

Other specified diseases of spinal cord, drug-induced

0.00

0.0

1.4

—

Other congenital malformations of integument

0.00

0.0

1.3

—

Birth injury to skeleton

0.00

0.0

1.0

—

Duodenal ulcer - Acute with haemorrhage, drug-induced

0.00

0.0

1.3

—

Fetal blood loss

0.00

0.0

1.2

—

Congenital malformations of anterior segment of eye

0.94

0.00

1.4

1.3

—

Malignant neoplasm of trachea

0.00

0.0

1.2

—

Drug-induced hypopituitarism

0.00

0.0

1.0

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

1.3

—

Iodine-deficiency-related thyroid disorders and allied conditions

0.00

0.0

1.3

—

Burns classified according to extent of body surface involved

0.92

0.00

1.2

—

Malignant neoplasm of pyriform sinus, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

Air embolism (traumatic)

0.00

0.0

1.4

—

Fat embolism (traumatic)

0.00

0.0

1.4

—

Other disorders of male genital organs

150

1.00

0.00

1.5

1.1

—

Bacterial meningoencephalitis and meningomyelitis

0.00

0.0

1.5

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

0.0

1.4

—

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

1.01

0.00

1.1

1.2

—

Disorder of amino-acid metabolism, other/unspecified

0.00

0.0

1.6

—

Other recurrent vertebral subluxation

0.00

0.0

1.1

—

Other injuries of spine and trunk, level unspecified

1.00

0.00

1.2

—

Benign neoplasm: Bronchus and lung

0.95

0.00

1.5

1.2

—

Other and unspecified injuries of neck

1.02

0.00

1.0

1.2

—

Traumatic amputation of forearm

0.00

0.0

1.4

—

Osteopathy after poliomyelitis

0.00

0.0

1.1

—

Use of apomorphine

0.00

0.0

1.4

—

Beta thalassaemia

0.00

0.0

1.2

—

Unspecified contact dermatitis due to drugs in contact with skin

0.00

0.0

1.8

—

Other and unspecified disorders of skin and subcutaneous tissue related to radiation

0.00

0.0

1.3

—

Exposure to excessive natural cold

0.98

0.00

1.0

1.3

—

Calcific tendinitis

0.96

0.00

1.4

1.2

—

Drowning and submersion in swimming-pool or bath

0.00

0.0

1.2

—

Alcoholic myopathy

0.00

0.0

1.3

—

Macular pucker, drug-induced

0.00

0.0

1.3

—

Combined immunodeficiency, unspecified

0.00

0.0

1.1

—

Cellulitis of external ear

0.98

0.00

1.1

1.2

—

Other specified and unspecified disorders of conjunctiva

0.98

0.00

1.2

1.1

—

Intentional self-harm by jumping or lying before moving object

0.00

0.0

1.3

—

Beau lines

0.00

0.0

1.4

—

Miliaria crystallina

0.00

0.0

1.0

—

Explosion and rupture of other specified pressurized devices

0.00

0.0

1.4

—

Accident to watercraft causing drowning and submersion

0.00

0.0

1.1

—

Calculus of urinary tract in diseases classified elsewhere

0.00

0.0

1.0

—

Exposure to noise

0.00

0.0

1.3

—

Drowning to ice

0.00

0.0

1.3

—

Obstetric and gynaecological devices associated with adverse incidents

0.00

0.0

1.2

—

Exposure to high and low air pressure and changes in air pressure

0.00

0.0

1.1

—

Universal erythroderma, KELA reimbursement

0.91

0.00

1.4

1.2

—

Medullary carcinoma of thyroid gland

0.00

0.0

1.3

—

Victim of lightning

0.00

0.0

1.2

—

Ophthalmic devices associated with adverse incidents

0.00

0.0

1.0

—

Pedal cyclist injured in collision with train or tram

0.00

0.0

1.2

—

Disorders of purine and pyrimidine metabolism, other/unspecified

0.00

0.0

1.3

—

Pedestrian injured in collision with railway train or railway vehicle

0.00

0.0

1.2

—

Defect, injury or illness of chest

0.00

0.0

1.1

—

Pregnant state, incidental

0.00

0.0

1.4

—

Need for immunization against combinations of infectious diseases

0.00

0.0

1.1

—

Dysplastic lesion of unknown severity of the cervix uteri

0.92

0.00

1.1

1.2

—

Forearm

0.00

0.0

1.3

—

Malignant neoplasm of other and ill-defined sites

0.00

0.0

1.2

—

Toxic effect of pesticides

0.00

0.0

1.3

—

Benign neoplasm: Aortic body and other paraganglia

0.00

0.0

1.0

—

Melanocytic naevi of lip

0.91

0.00

1.5

1.1

—

Lymphangioma, anys site

1.02

0.00

1.5

1.1

—

Traumatic amputation of shoulder and upper arm

0.00

0.0

1.3

—

Melanocytic naevi of eyelid, including canthus

1.00

0.00

1.1

1.2

—

Irritant contact dermatitis due to drugs in contact with skin

0.00

0.0

1.0

—

Injury of nerves at ankle and foot level

0.94

0.00

1.0

1.3

—

Disorders of conjunctiva in diseases classified elsewhere

0.00

0.0

1.3

—

Choroidal detachment

0.00

0.0

1.4

—

Benign neoplasm: Mesothelial tissue of other sites/unspecified

0.00

0.0

1.2

—

Frostbite

0.95

0.00

1.0

1.2

—

Abuse of non-dependence-producing substances

0.00

0.0

1.2

—

Benign neoplasm: Trachea

0.00

0.0

1.3

—

Carcinoma in situ of colon

0.94

0.00

1.0

1.1

—

Neurological devices associated with adverse incidents

0.00

0.0

1.3

—

Benign neoplasm: Male genital organ, other/unspecified

0.00

0.0

1.2

—

Carcinoma in situ of bronchus and lung

0.00

0.0

1.4

—

Exposure to excessive cold of man-made origin

0.00

0.0

1.1

—

Organic amnesic syndrome, not induced by alcohol and other psychoactive substances

0.00

0.0

1.3

—

Leptospirosis

0.00

0.0

1.4

—

Carcinoma in situ of liver, gallbladder and bile ducts

0.00

0.0

1.2

—

Crushing injury of hip and thigh

0.00

0.0

1.4

—

Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli]

0.00

0.0

1.2

—

Induced delusional disorder

0.00

0.0

1.1

—

Miliaria rubra

0.00

0.0

1.0

—

Kwashiorkor

0.00

0.0

1.2

—

Non-neuropathic heredofamilial amyloidosis

0.00

0.0

1.3

—

Histoplasmosis

0.00

0.0

1.2

—

Keratosis follicularis et parafollicularis in cutem penetrans [Kyrle]

0.00

0.0

1.2

—

Benign neoplasm: Spinal meninges

1.00

0.00

1.4

1.2

—

Benign neoplasm: Trachea

0.00

0.0

1.4

—

Other and unspecified disorders of refraction

0.00

0.0

1.4

—

Labyrinthine dysfunction

0.00

0.0

1.5

—

Anetoderma (of Jadassohn-Pellizzari/Pasini and pierini)

0.00

0.0

1.1

—

Nocardiosis

0.00

0.0

1.3

—

Unspecified visual impairment (binocular)

1.01

0.00

1.6

1.2

—

Drug photoallergic response

0.00

0.0

1.2

—

Benign neoplasm: Bronchus and lung

0.94

0.00

1.5

1.2

—

Genetic anomalies of leukocytes

0.00

0.0

1.3

—

Hereditary choroidal dystrophy

0.00

0.0

1.1

—

Hereditary elliptocytosis

0.00

0.0

1.3

—

Sclerosis of liver

0.00

0.0

1.3

—

Trichomoniasis

0.89

0.00

1.2

—

Benign neoplasm of mesothelial tissue

0.00

0.0

1.4

—

Nutritional marasmus

0.00

0.0

1.3

—

Other congenital malformations of spinal cord

0.00

0.0

1.6

—

Drug-induced nonautoimmune haemolytic anaemia

0.00

0.0

1.6

—

Huntington disease

0.00

0.0

1.2

—

Immunodeficiency with increased immunoglobulin M [IgM]

0.00

0.0

1.3

—

Duodenal ulcer - Acute without haemorrhage or perforation, drug-induced

0.00

0.0

1.2

—

Plasmodium vivax malaria

0.00

0.0

1.2

—

Profound mental retardation

0.00

0.0

1.3

—

Carcinoma in situ of larynx

0.00

0.0

1.4

—

Diastrofic dysplasy

0.00

0.0

1.4

—

Biliary cirrhosis, secondary

0.00

0.0

1.2

—

Acné excoriée

0.00

-0.00

0.0

1.2

—

Severe combined immunodeficiency [SCID] with low or normal B-cell numbers

0.00

-0.00

0.0

1.2

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS